LOCUS       NM_001126117            2063 bp    mRNA    linear   PRI 12-JUN-2025
DEFINITION  Homo sapiens tumor protein p53 (TP53), transcript variant 7, mRNA.
ACCESSION   NM_001126117
VERSION     NM_001126117.2
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (bases 1 to 2063)
  AUTHORS   Mirgayazova,R., Khadiullina,R., Chasov,V., Mingaleeva,R.,
            Miftakhova,R., Rizvanov,A. and Bulatov,E.
  TITLE     Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option?
  JOURNAL   Genes (Basel) 11 (6), 704 (2020)
   PUBMED   32630614
  REMARK    GeneRIF: Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an
            Option? Review article Publication Status: Online-Only
REFERENCE   2  (bases 1 to 2063)
  AUTHORS   Flynt,E., Bisht,K., Sridharan,V., Ortiz,M., Towfic,F. and
            Thakurta,A.
  TITLE     Prognosis, Biology, and Targeting of TP53 Dysregulation in Multiple
            Myeloma
  JOURNAL   Cells 9 (2), 287 (2020)
   PUBMED   31991614
  REMARK    Review article Publication Status: Online-Only
REFERENCE   3  (bases 1 to 2063)
  AUTHORS   Barnoud,T., Parris,J.L.D. and Murphy,M.E.
  TITLE     Common genetic variants in the TP53 pathway and their impact on
            cancer
  JOURNAL   J Mol Cell Biol 11 (7), 578-585 (2019)
   PUBMED   31152665
  REMARK    GeneRIF: Common genetic variants in the TP53 pathway and their
            impact on cancer. Review article
REFERENCE   4  (bases 1 to 2063)
  AUTHORS   Hu,W., Chen,S., Thorne,R.F. and Wu,M.
  TITLE     TP53, TP53 Target Genes (DRAM, TIGAR), and Autophagy
  JOURNAL   Adv Exp Med Biol 1206, 127-149 (2019)
   PUBMED   31776983
  REMARK    Review article
REFERENCE   5  (bases 1 to 2063)
  AUTHORS   Baugh,E.H., Ke,H., Levine,A.J., Bonneau,R.A. and Chan,C.S.
  TITLE     Why are there hotspot mutations in the TP53 gene in human cancers?
  JOURNAL   Cell Death Differ 25 (1), 154-160 (2018)
   PUBMED   29099487
  REMARK    GeneRIF: TP53 missense mutant alleles that occur in human cancers
            are discussed in the context of high resolution models of these p53
            mutant protein structures to determine the structural features of
            mutations (review). Review article
REFERENCE   6  (bases 1 to 2063)
  AUTHORS   Aubrey,B.J., Strasser,A. and Kelly,G.L.
  TITLE     Tumor-Suppressor Functions of the TP53 Pathway
  JOURNAL   Cold Spring Harb Perspect Med 6 (5), a026062 (2016)
   PUBMED   27141080
  REMARK    Review article Publication Status: Online-Only
REFERENCE   7  (bases 1 to 2063)
  AUTHORS   Soussi,T. and Wiman,K.G.
  TITLE     TP53: an oncogene in disguise
  JOURNAL   Cell Death Differ 22 (8), 1239-1249 (2015)
   PUBMED   26024390
  REMARK    Review article
REFERENCE   8  (bases 1 to 2063)
  AUTHORS   Soussi,T.
  TITLE     The TP53 gene network in a postgenomic era
  JOURNAL   Hum Mutat 35 (6), 641-642 (2014)
   PUBMED   24753184
  REMARK    GeneRIF: Recommendations and guidelines for reporting and annotating
            TP53 variants are also provided, to help researchers generate
            standardized data that are easy to understand, analyze, and exchange
            across various cancer variant databases Review article
REFERENCE   9  (bases 1 to 2063)
  AUTHORS   Anczukow,O., Ware,M.D., Buisson,M., Zetoune,A.B., Stoppa-Lyonnet,D.,
            Sinilnikova,O.M. and Mazoyer,S.
  TITLE     Does the nonsense-mediated mRNA decay mechanism prevent the
            synthesis of truncated BRCA1, CHK2, and p53 proteins?
  JOURNAL   Hum Mutat 29 (1), 65-73 (2008)
   PUBMED   17694537
  REMARK    GeneRIF: the p53 protein encoded by the 770delT allele is as
            abundant as the wild-type protein, as removal of the C-terminal p53
            domain leads to a stabilized mutant protein, whose abundance is
            markedly increased when NMD is inhibited.
REFERENCE   10  (bases 1 to 2063)
  AUTHORS   Bourdon,J.C.
  TITLE     p53 Family isoforms
  JOURNAL   Curr Pharm Biotechnol 8 (6), 332-336 (2007)
   PUBMED   18289041
  REMARK    Review article
REFERENCE   11  (bases 1 to 2063)
  AUTHORS   Candeias,M.M., Powell,D.J., Roubalova,E., Apcher,S., Bourougaa,K.,
            Vojtesek,B., Bruzzoni-Giovanelli,H. and Fahraeus,R.
  TITLE     Expression of p53 and p53/47 are controlled by alternative
            mechanisms of messenger RNA translation initiation
  JOURNAL   Oncogene 25 (52), 6936-6947 (2006)
   PUBMED   16983332
  REMARK    GeneRIF: harbouring alternative translation initiation sites, the
            p53 mRNA gives rise to different levels of the p53 isoforms which
            help to orchestrate the cell biological outcome of p53 activation
REFERENCE   12  (bases 1 to 2063)
  AUTHORS   Murray-Zmijewski,F., Lane,D.P. and Bourdon,J.C.
  TITLE     p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell
            differentiation and response to stress
  JOURNAL   Cell Death Differ 13 (6), 962-972 (2006)
   PUBMED   16601753
  REMARK    Review article
REFERENCE   13  (bases 1 to 2063)
  AUTHORS   Bourdon,J.C., Fernandes,K., Murray-Zmijewski,F., Liu,G., Diot,A.,
            Xirodimas,D.P., Saville,M.K. and Lane,D.P.
  TITLE     p53 isoforms can regulate p53 transcriptional activity
  JOURNAL   Genes Dev 19 (18), 2122-2137 (2005)
   PUBMED   16131611
  REMARK    GeneRIF: p53 isoforms can regulate p53 transcriptional activity.
REFERENCE   14  (bases 1 to 2063)
  AUTHORS   Ghosh,A., Stewart,D. and Matlashewski,G.
  TITLE     Regulation of human p53 activity and cell localization by
            alternative splicing
  JOURNAL   Mol Cell Biol 24 (18), 7987-7997 (2004)
   PUBMED   15340061
  REMARK    GeneRIF: mechanism of p53 regulation originating through alternative
            splicing of the human p53 gene resulting in the expression of a
            novel p53 mRNA
REFERENCE   15  (bases 1 to 2063)
  AUTHORS   Flaman,J.M., Waridel,F., Estreicher,A., Vannier,A., Limacher,J.M.,
            Gilbert,D., Iggo,R. and Frebourg,T.
  TITLE     The human tumour suppressor gene p53 is alternatively spliced in
            normal cells
  JOURNAL   Oncogene 12 (4), 813-818 (1996)
   PUBMED   8632903
REFERENCE   16  (bases 1 to 2063)
  AUTHORS   Schneider,K., Zelley,K., Nichols,K.E., Schwartz Levine,A. and
            Garber,J.
  TITLE     Li-Fraumeni Syndrome
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE and Amemiya
            A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301488
REFERENCE   17  (bases 1 to 2063)
  AUTHORS   Turner,J.T., Brzezinski,J. and Dome,J.S.
  TITLE     Wilms Tumor Predisposition
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE and Amemiya
            A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301471
REFERENCE   18  (bases 1 to 2063)
  AUTHORS   Lamb,P. and Crawford,L.
  TITLE     Characterization of the human p53 gene
  JOURNAL   Mol Cell Biol 6 (5), 1379-1385 (1986)
   PUBMED   2946935
REFERENCE   19  (bases 1 to 2063)
  AUTHORS   Isobe,M., Emanuel,B.S., Givol,D., Oren,M. and Croce,C.M.
  TITLE     Localization of gene for human p53 tumour antigen to band 17p13
  JOURNAL   Nature 320 (6057), 84-85 (1986)
   PUBMED   3456488
REFERENCE   20  (bases 1 to 2063)
  AUTHORS   Benchimol,S., Lamb,P., Crawford,L.V., Sheer,D., Shows,T.B.,
            Bruns,G.A. and Peacock,J.
  TITLE     Transformation associated p53 protein is encoded by a gene on human
            chromosome 17
  JOURNAL   Somat Cell Mol Genet 11 (5), 505-510 (1985)
   PUBMED   2994241
REFERENCE   21  (bases 1 to 2063)
  AUTHORS   Harlow,E., Williamson,N.M., Ralston,R., Helfman,D.M. and Adams,T.E.
  TITLE     Molecular cloning and in vitro expression of a cDNA clone for human
            cellular tumor antigen p53
  JOURNAL   Mol Cell Biol 5 (7), 1601-1610 (1985)
   PUBMED   3894933
REFERENCE   22  (bases 1 to 2063)
  AUTHORS   Zakut-Houri,R., Bienz-Tadmor,B., Givol,D. and Oren,M.
  TITLE     Human p53 cellular tumor antigen: cDNA sequence and expression in
            COS cells
  JOURNAL   EMBO J 4 (5), 1251-1255 (1985)
   PUBMED   4006916
REFERENCE   23  (bases 1 to 2063)
  AUTHORS   Matlashewski,G., Lamb,P., Pim,D., Peacock,J., Crawford,L. and
            Benchimol,S.
  TITLE     Isolation and characterization of a human p53 cDNA clone: expression
            of the human p53 gene
  JOURNAL   EMBO J 3 (13), 3257-3262 (1984)
   PUBMED   6396087
COMMENT     ##Evidence-Data-START##
            Transcript exon combination :: DQ186652.1 [ECO:0000332]
            RNAseq introns :: mixed sample support SAMEA1965299, SAMEA1966682
            [ECO:0006172]
            ##Evidence-Data-END##
            ##RefSeq-Attributes-START##
            NMD candidate               :: translation inferred
            ##RefSeq-Attributes-END##
            REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from AC087388.9 and AC007421.13.
            On Aug 21, 2020 this sequence version replaced NM_001126117.1.
            Summary: This gene encodes a tumor suppressor protein containing
            transcriptional activation, DNA binding, and oligomerization
            domains. The encoded protein responds to diverse cellular stresses
            to regulate expression of target genes, thereby inducing cell cycle
            arrest, apoptosis, senescence, DNA repair, or changes in
            metabolism. Mutations in this gene are associated with a variety of
            human cancers, including hereditary cancers such as Li-Fraumeni
            syndrome. Alternative splicing of this gene and the use of
            alternate promoters result in multiple transcript variants and
            isoforms. Additional isoforms have also been shown to result from
            the use of alternate translation initiation codons from identical
            transcript variants (PMIDs: 12032546, 20937277). [provided by
            RefSeq, Dec 2016].
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            COMPLETENESS: full length.
FEATURES             Location/Qualifiers
     source          1..2063
                     /organism="Homo sapiens"
                     /mol_type="mRNA"
                     /db_xref="taxon:9606"
                     /chromosome="17"
                     /map="17p13.1"
     gene            1..2063
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="tumor protein p53"
                     /db_xref="GeneID:7157"
                     /db_xref="HGNC:HGNC:11998"
                     /db_xref="MIM:191170"
     exon            1..192
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     CDS             30..674
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="isoform f is encoded by transcript variant 7; tumor
                     protein 53; mutant tumor protein 53; cellular tumor antigen
                     p53; phosphoprotein p53; transformation-related protein 53;
                     antigen NY-CO-13; tumor supressor p53"
                     /codon_start=1
                     /product="cellular tumor antigen p53 isoform f"
                     /protein_id="NP_001119589.1"
                     /db_xref="CCDS:CCDS73967.1"
                     /db_xref="GeneID:7157"
                     /db_xref="HGNC:HGNC:11998"
                     /db_xref="MIM:191170"
                     /translation="MFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCP
                     HHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNY
                     MCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVRVCACPGRDRRTEEENLRKKGEP
                     HHELPPGSTKRALPNNTSSSPQPKKKPLDGEYFTLQMLLDLRWCYFLINSS"
     misc_feature    111..113
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="delta160p53gamma; Region: alternative start codon"
     exon            193..305
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            306..415
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            416..552
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            553..626
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            627..686
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            687..793
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            794..2063
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     regulatory      2046..2051
                     /regulatory_class="polyA_signal_sequence"
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="hexamer: AATAAA"
     polyA_site      2063
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="major polyA site"
ORIGIN
        1 tcctacagta ctcccctgcc ctcaacaaga tgttttgcca actggccaag acctgccctg
       61 tgcagctgtg ggttgattcc acacccccgc ccggcacccg cgtccgcgcc atggccatct
      121 acaagcagtc acagcacatg acggaggttg tgaggcgctg cccccaccat gagcgctgct
      181 cagatagcga tggtctggcc cctcctcagc atcttatccg agtggaagga aatttgcgtg
      241 tggagtattt ggatgacaga aacacttttc gacatagtgt ggtggtgccc tatgagccgc
      301 ctgaggttgg ctctgactgt accaccatcc actacaacta catgtgtaac agttcctgca
      361 tgggcggcat gaaccggagg cccatcctca ccatcatcac actggaagac tccagtggta
      421 atctactggg acggaacagc tttgaggtgc gtgtttgtgc ctgtcctggg agagaccggc
      481 gcacagagga agagaatctc cgcaagaaag gggagcctca ccacgagctg cccccaggga
      541 gcactaagcg agcactgccc aacaacacca gctcctctcc ccagccaaag aagaaaccac
      601 tggatggaga atatttcacc cttcagatgc tacttgactt acgatggtgt tacttcctga
      661 taaactcgtc gtaagttgaa aatattatcc gtgggcgtga gcgcttcgag atgttccgag
      721 agctgaatga ggccttggaa ctcaaggatg cccaggctgg gaaggagcca ggggggagca
      781 gggctcactc cagccacctg aagtccaaaa agggtcagtc tacctcccgc cataaaaaac
      841 tcatgttcaa gacagaaggg cctgactcag actgacattc tccacttctt gttccccact
      901 gacagcctcc cacccccatc tctccctccc ctgccatttt gggttttggg tctttgaacc
      961 cttgcttgca ataggtgtgc gtcagaagca cccaggactt ccatttgctt tgtcccgggg
     1021 ctccactgaa caagttggcc tgcactggtg ttttgttgtg gggaggagga tggggagtag
     1081 gacataccag cttagatttt aaggttttta ctgtgaggga tgtttgggag atgtaagaaa
     1141 tgttcttgca gttaagggtt agtttacaat cagccacatt ctaggtaggg gcccacttca
     1201 ccgtactaac cagggaagct gtccctcact gttgaatttt ctctaacttc aaggcccata
     1261 tctgtgaaat gctggcattt gcacctacct cacagagtgc attgtgaggg ttaatgaaat
     1321 aatgtacatc tggccttgaa accacctttt attacatggg gtctagaact tgaccccctt
     1381 gagggtgctt gttccctctc cctgttggtc ggtgggttgg tagtttctac agttgggcag
     1441 ctggttaggt agagggagtt gtcaagtctc tgctggccca gccaaaccct gtctgacaac
     1501 ctcttggtga accttagtac ctaaaaggaa atctcacccc atcccacacc ctggaggatt
     1561 tcatctcttg tatatgatga tctggatcca ccaagacttg ttttatgctc agggtcaatt
     1621 tcttttttct tttttttttt tttttttctt tttctttgag actgggtctc gctttgttgc
     1681 ccaggctgga gtggagtggc gtgatcttgg cttactgcag cctttgcctc cccggctcga
     1741 gcagtcctgc ctcagcctcc ggagtagctg ggaccacagg ttcatgccac catggccagc
     1801 caacttttgc atgttttgta gagatggggt ctcacagtgt tgcccaggct ggtctcaaac
     1861 tcctgggctc aggcgatcca cctgtctcag cctcccagag tgctgggatt acaattgtga
     1921 gccaccacgt ccagctggaa gggtcaacat cttttacatt ctgcaagcac atctgcattt
     1981 tcaccccacc cttcccctcc ttctcccttt ttatatccca tttttatatc gatctcttat
     2041 tttacaataa aactttgctg cca
//
LOCUS       NM_001126115            2003 bp    mRNA    linear   PRI 12-JUN-2025
DEFINITION  Homo sapiens tumor protein p53 (TP53), transcript variant 5, mRNA.
ACCESSION   NM_001126115
VERSION     NM_001126115.2
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (bases 1 to 2003)
  AUTHORS   Mirgayazova,R., Khadiullina,R., Chasov,V., Mingaleeva,R.,
            Miftakhova,R., Rizvanov,A. and Bulatov,E.
  TITLE     Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option?
  JOURNAL   Genes (Basel) 11 (6), 704 (2020)
   PUBMED   32630614
  REMARK    GeneRIF: Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an
            Option? Review article Publication Status: Online-Only
REFERENCE   2  (bases 1 to 2003)
  AUTHORS   Flynt,E., Bisht,K., Sridharan,V., Ortiz,M., Towfic,F. and
            Thakurta,A.
  TITLE     Prognosis, Biology, and Targeting of TP53 Dysregulation in Multiple
            Myeloma
  JOURNAL   Cells 9 (2), 287 (2020)
   PUBMED   31991614
  REMARK    Review article Publication Status: Online-Only
REFERENCE   3  (bases 1 to 2003)
  AUTHORS   Barnoud,T., Parris,J.L.D. and Murphy,M.E.
  TITLE     Common genetic variants in the TP53 pathway and their impact on
            cancer
  JOURNAL   J Mol Cell Biol 11 (7), 578-585 (2019)
   PUBMED   31152665
  REMARK    GeneRIF: Common genetic variants in the TP53 pathway and their
            impact on cancer. Review article
REFERENCE   4  (bases 1 to 2003)
  AUTHORS   Hu,W., Chen,S., Thorne,R.F. and Wu,M.
  TITLE     TP53, TP53 Target Genes (DRAM, TIGAR), and Autophagy
  JOURNAL   Adv Exp Med Biol 1206, 127-149 (2019)
   PUBMED   31776983
  REMARK    Review article
REFERENCE   5  (bases 1 to 2003)
  AUTHORS   Baugh,E.H., Ke,H., Levine,A.J., Bonneau,R.A. and Chan,C.S.
  TITLE     Why are there hotspot mutations in the TP53 gene in human cancers?
  JOURNAL   Cell Death Differ 25 (1), 154-160 (2018)
   PUBMED   29099487
  REMARK    GeneRIF: TP53 missense mutant alleles that occur in human cancers
            are discussed in the context of high resolution models of these p53
            mutant protein structures to determine the structural features of
            mutations (review). Review article
REFERENCE   6  (bases 1 to 2003)
  AUTHORS   Aubrey,B.J., Strasser,A. and Kelly,G.L.
  TITLE     Tumor-Suppressor Functions of the TP53 Pathway
  JOURNAL   Cold Spring Harb Perspect Med 6 (5), a026062 (2016)
   PUBMED   27141080
  REMARK    Review article Publication Status: Online-Only
REFERENCE   7  (bases 1 to 2003)
  AUTHORS   Soussi,T. and Wiman,K.G.
  TITLE     TP53: an oncogene in disguise
  JOURNAL   Cell Death Differ 22 (8), 1239-1249 (2015)
   PUBMED   26024390
  REMARK    Review article
REFERENCE   8  (bases 1 to 2003)
  AUTHORS   Soussi,T.
  TITLE     The TP53 gene network in a postgenomic era
  JOURNAL   Hum Mutat 35 (6), 641-642 (2014)
   PUBMED   24753184
  REMARK    GeneRIF: Recommendations and guidelines for reporting and annotating
            TP53 variants are also provided, to help researchers generate
            standardized data that are easy to understand, analyze, and exchange
            across various cancer variant databases Review article
REFERENCE   9  (bases 1 to 2003)
  AUTHORS   Anczukow,O., Ware,M.D., Buisson,M., Zetoune,A.B., Stoppa-Lyonnet,D.,
            Sinilnikova,O.M. and Mazoyer,S.
  TITLE     Does the nonsense-mediated mRNA decay mechanism prevent the
            synthesis of truncated BRCA1, CHK2, and p53 proteins?
  JOURNAL   Hum Mutat 29 (1), 65-73 (2008)
   PUBMED   17694537
  REMARK    GeneRIF: the p53 protein encoded by the 770delT allele is as
            abundant as the wild-type protein, as removal of the C-terminal p53
            domain leads to a stabilized mutant protein, whose abundance is
            markedly increased when NMD is inhibited.
REFERENCE   10  (bases 1 to 2003)
  AUTHORS   Bourdon,J.C.
  TITLE     p53 Family isoforms
  JOURNAL   Curr Pharm Biotechnol 8 (6), 332-336 (2007)
   PUBMED   18289041
  REMARK    Review article
REFERENCE   11  (bases 1 to 2003)
  AUTHORS   Candeias,M.M., Powell,D.J., Roubalova,E., Apcher,S., Bourougaa,K.,
            Vojtesek,B., Bruzzoni-Giovanelli,H. and Fahraeus,R.
  TITLE     Expression of p53 and p53/47 are controlled by alternative
            mechanisms of messenger RNA translation initiation
  JOURNAL   Oncogene 25 (52), 6936-6947 (2006)
   PUBMED   16983332
  REMARK    GeneRIF: harbouring alternative translation initiation sites, the
            p53 mRNA gives rise to different levels of the p53 isoforms which
            help to orchestrate the cell biological outcome of p53 activation
REFERENCE   12  (bases 1 to 2003)
  AUTHORS   Murray-Zmijewski,F., Lane,D.P. and Bourdon,J.C.
  TITLE     p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell
            differentiation and response to stress
  JOURNAL   Cell Death Differ 13 (6), 962-972 (2006)
   PUBMED   16601753
  REMARK    Review article
REFERENCE   13  (bases 1 to 2003)
  AUTHORS   Bourdon,J.C., Fernandes,K., Murray-Zmijewski,F., Liu,G., Diot,A.,
            Xirodimas,D.P., Saville,M.K. and Lane,D.P.
  TITLE     p53 isoforms can regulate p53 transcriptional activity
  JOURNAL   Genes Dev 19 (18), 2122-2137 (2005)
   PUBMED   16131611
  REMARK    GeneRIF: p53 isoforms can regulate p53 transcriptional activity.
REFERENCE   14  (bases 1 to 2003)
  AUTHORS   Ghosh,A., Stewart,D. and Matlashewski,G.
  TITLE     Regulation of human p53 activity and cell localization by
            alternative splicing
  JOURNAL   Mol Cell Biol 24 (18), 7987-7997 (2004)
   PUBMED   15340061
  REMARK    GeneRIF: mechanism of p53 regulation originating through alternative
            splicing of the human p53 gene resulting in the expression of a
            novel p53 mRNA
REFERENCE   15  (bases 1 to 2003)
  AUTHORS   Flaman,J.M., Waridel,F., Estreicher,A., Vannier,A., Limacher,J.M.,
            Gilbert,D., Iggo,R. and Frebourg,T.
  TITLE     The human tumour suppressor gene p53 is alternatively spliced in
            normal cells
  JOURNAL   Oncogene 12 (4), 813-818 (1996)
   PUBMED   8632903
REFERENCE   16  (bases 1 to 2003)
  AUTHORS   Schneider,K., Zelley,K., Nichols,K.E., Schwartz Levine,A. and
            Garber,J.
  TITLE     Li-Fraumeni Syndrome
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE and Amemiya
            A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301488
REFERENCE   17  (bases 1 to 2003)
  AUTHORS   Turner,J.T., Brzezinski,J. and Dome,J.S.
  TITLE     Wilms Tumor Predisposition
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE and Amemiya
            A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301471
REFERENCE   18  (bases 1 to 2003)
  AUTHORS   Lamb,P. and Crawford,L.
  TITLE     Characterization of the human p53 gene
  JOURNAL   Mol Cell Biol 6 (5), 1379-1385 (1986)
   PUBMED   2946935
REFERENCE   19  (bases 1 to 2003)
  AUTHORS   Isobe,M., Emanuel,B.S., Givol,D., Oren,M. and Croce,C.M.
  TITLE     Localization of gene for human p53 tumour antigen to band 17p13
  JOURNAL   Nature 320 (6057), 84-85 (1986)
   PUBMED   3456488
REFERENCE   20  (bases 1 to 2003)
  AUTHORS   Benchimol,S., Lamb,P., Crawford,L.V., Sheer,D., Shows,T.B.,
            Bruns,G.A. and Peacock,J.
  TITLE     Transformation associated p53 protein is encoded by a gene on human
            chromosome 17
  JOURNAL   Somat Cell Mol Genet 11 (5), 505-510 (1985)
   PUBMED   2994241
REFERENCE   21  (bases 1 to 2003)
  AUTHORS   Harlow,E., Williamson,N.M., Ralston,R., Helfman,D.M. and Adams,T.E.
  TITLE     Molecular cloning and in vitro expression of a cDNA clone for human
            cellular tumor antigen p53
  JOURNAL   Mol Cell Biol 5 (7), 1601-1610 (1985)
   PUBMED   3894933
REFERENCE   22  (bases 1 to 2003)
  AUTHORS   Zakut-Houri,R., Bienz-Tadmor,B., Givol,D. and Oren,M.
  TITLE     Human p53 cellular tumor antigen: cDNA sequence and expression in
            COS cells
  JOURNAL   EMBO J 4 (5), 1251-1255 (1985)
   PUBMED   4006916
REFERENCE   23  (bases 1 to 2003)
  AUTHORS   Matlashewski,G., Lamb,P., Pim,D., Peacock,J., Crawford,L. and
            Benchimol,S.
  TITLE     Isolation and characterization of a human p53 cDNA clone: expression
            of the human p53 gene
  JOURNAL   EMBO J 3 (13), 3257-3262 (1984)
   PUBMED   6396087
COMMENT     ##Evidence-Data-START##
            Transcript exon combination :: DQ186650.1, SRR14038193.783535.1
            [ECO:0000332]
            RNAseq introns :: mixed sample support SAMEA1965299, SAMEA1966682
            [ECO:0006172]
            ##Evidence-Data-END##
            REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from AC087388.9 and AC007421.13.
            On Aug 21, 2020 this sequence version replaced NM_001126115.1.
            Summary: This gene encodes a tumor suppressor protein containing
            transcriptional activation, DNA binding, and oligomerization
            domains. The encoded protein responds to diverse cellular stresses
            to regulate expression of target genes, thereby inducing cell cycle
            arrest, apoptosis, senescence, DNA repair, or changes in
            metabolism. Mutations in this gene are associated with a variety of
            human cancers, including hereditary cancers such as Li-Fraumeni
            syndrome. Alternative splicing of this gene and the use of
            alternate promoters result in multiple transcript variants and
            isoforms. Additional isoforms have also been shown to result from
            the use of alternate translation initiation codons from identical
            transcript variants (PMIDs: 12032546, 20937277). [provided by
            RefSeq, Dec 2016].
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            COMPLETENESS: full length.
FEATURES             Location/Qualifiers
     source          1..2003
                     /organism="Homo sapiens"
                     /mol_type="mRNA"
                     /db_xref="taxon:9606"
                     /chromosome="17"
                     /map="17p13.1"
     gene            1..2003
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="tumor protein p53"
                     /db_xref="GeneID:7157"
                     /db_xref="HGNC:HGNC:11998"
                     /db_xref="MIM:191170"
     exon            1..192
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     CDS             30..815
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="isoform d is encoded by transcript variant 5; tumor
                     protein 53; mutant tumor protein 53; cellular tumor antigen
                     p53; phosphoprotein p53; transformation-related protein 53;
                     antigen NY-CO-13; tumor supressor p53"
                     /codon_start=1
                     /product="cellular tumor antigen p53 isoform d"
                     /protein_id="NP_001119587.1"
                     /db_xref="CCDS:CCDS73966.1"
                     /db_xref="GeneID:7157"
                     /db_xref="HGNC:HGNC:11998"
                     /db_xref="MIM:191170"
                     /translation="MFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCP
                     HHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNY
                     MCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVRVCACPGRDRRTEEENLRKKGEP
                     HHELPPGSTKRALPNNTSSSPQPKKKPLDGEYFTLQIRGRERFEMFRELNEALELKDAQ
                     AGKEPGGSRAHSSHLKSKKGQSTSRHKKLMFKTEGPDSD"
     misc_feature    111..113
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="delta133p53alpha; Region: alternative start codon"
     exon            193..305
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            306..415
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            416..552
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            553..626
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            627..733
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            734..2003
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     regulatory      1986..1991
                     /regulatory_class="polyA_signal_sequence"
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="hexamer: AATAAA"
     polyA_site      2003
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="major polyA site"
ORIGIN
        1 tcctacagta ctcccctgcc ctcaacaaga tgttttgcca actggccaag acctgccctg
       61 tgcagctgtg ggttgattcc acacccccgc ccggcacccg cgtccgcgcc atggccatct
      121 acaagcagtc acagcacatg acggaggttg tgaggcgctg cccccaccat gagcgctgct
      181 cagatagcga tggtctggcc cctcctcagc atcttatccg agtggaagga aatttgcgtg
      241 tggagtattt ggatgacaga aacacttttc gacatagtgt ggtggtgccc tatgagccgc
      301 ctgaggttgg ctctgactgt accaccatcc actacaacta catgtgtaac agttcctgca
      361 tgggcggcat gaaccggagg cccatcctca ccatcatcac actggaagac tccagtggta
      421 atctactggg acggaacagc tttgaggtgc gtgtttgtgc ctgtcctggg agagaccggc
      481 gcacagagga agagaatctc cgcaagaaag gggagcctca ccacgagctg cccccaggga
      541 gcactaagcg agcactgccc aacaacacca gctcctctcc ccagccaaag aagaaaccac
      601 tggatggaga atatttcacc cttcagatcc gtgggcgtga gcgcttcgag atgttccgag
      661 agctgaatga ggccttggaa ctcaaggatg cccaggctgg gaaggagcca ggggggagca
      721 gggctcactc cagccacctg aagtccaaaa agggtcagtc tacctcccgc cataaaaaac
      781 tcatgttcaa gacagaaggg cctgactcag actgacattc tccacttctt gttccccact
      841 gacagcctcc cacccccatc tctccctccc ctgccatttt gggttttggg tctttgaacc
      901 cttgcttgca ataggtgtgc gtcagaagca cccaggactt ccatttgctt tgtcccgggg
      961 ctccactgaa caagttggcc tgcactggtg ttttgttgtg gggaggagga tggggagtag
     1021 gacataccag cttagatttt aaggttttta ctgtgaggga tgtttgggag atgtaagaaa
     1081 tgttcttgca gttaagggtt agtttacaat cagccacatt ctaggtaggg gcccacttca
     1141 ccgtactaac cagggaagct gtccctcact gttgaatttt ctctaacttc aaggcccata
     1201 tctgtgaaat gctggcattt gcacctacct cacagagtgc attgtgaggg ttaatgaaat
     1261 aatgtacatc tggccttgaa accacctttt attacatggg gtctagaact tgaccccctt
     1321 gagggtgctt gttccctctc cctgttggtc ggtgggttgg tagtttctac agttgggcag
     1381 ctggttaggt agagggagtt gtcaagtctc tgctggccca gccaaaccct gtctgacaac
     1441 ctcttggtga accttagtac ctaaaaggaa atctcacccc atcccacacc ctggaggatt
     1501 tcatctcttg tatatgatga tctggatcca ccaagacttg ttttatgctc agggtcaatt
     1561 tcttttttct tttttttttt tttttttctt tttctttgag actgggtctc gctttgttgc
     1621 ccaggctgga gtggagtggc gtgatcttgg cttactgcag cctttgcctc cccggctcga
     1681 gcagtcctgc ctcagcctcc ggagtagctg ggaccacagg ttcatgccac catggccagc
     1741 caacttttgc atgttttgta gagatggggt ctcacagtgt tgcccaggct ggtctcaaac
     1801 tcctgggctc aggcgatcca cctgtctcag cctcccagag tgctgggatt acaattgtga
     1861 gccaccacgt ccagctggaa gggtcaacat cttttacatt ctgcaagcac atctgcattt
     1921 tcaccccacc cttcccctcc ttctcccttt ttatatccca tttttatatc gatctcttat
     1981 tttacaataa aactttgctg cca
//
LOCUS       NM_001126118            2629 bp    mRNA    linear   PRI 12-JUN-2025
DEFINITION  Homo sapiens tumor protein p53 (TP53), transcript variant 8, mRNA.
ACCESSION   NM_001126118
VERSION     NM_001126118.2
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (bases 1 to 2629)
  AUTHORS   Mirgayazova,R., Khadiullina,R., Chasov,V., Mingaleeva,R.,
            Miftakhova,R., Rizvanov,A. and Bulatov,E.
  TITLE     Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option?
  JOURNAL   Genes (Basel) 11 (6), 704 (2020)
   PUBMED   32630614
  REMARK    GeneRIF: Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an
            Option? Review article Publication Status: Online-Only
REFERENCE   2  (bases 1 to 2629)
  AUTHORS   Flynt,E., Bisht,K., Sridharan,V., Ortiz,M., Towfic,F. and
            Thakurta,A.
  TITLE     Prognosis, Biology, and Targeting of TP53 Dysregulation in Multiple
            Myeloma
  JOURNAL   Cells 9 (2), 287 (2020)
   PUBMED   31991614
  REMARK    Review article Publication Status: Online-Only
REFERENCE   3  (bases 1 to 2629)
  AUTHORS   Barnoud,T., Parris,J.L.D. and Murphy,M.E.
  TITLE     Common genetic variants in the TP53 pathway and their impact on
            cancer
  JOURNAL   J Mol Cell Biol 11 (7), 578-585 (2019)
   PUBMED   31152665
  REMARK    GeneRIF: Common genetic variants in the TP53 pathway and their
            impact on cancer. Review article
REFERENCE   4  (bases 1 to 2629)
  AUTHORS   Hu,W., Chen,S., Thorne,R.F. and Wu,M.
  TITLE     TP53, TP53 Target Genes (DRAM, TIGAR), and Autophagy
  JOURNAL   Adv Exp Med Biol 1206, 127-149 (2019)
   PUBMED   31776983
  REMARK    Review article
REFERENCE   5  (bases 1 to 2629)
  AUTHORS   Baugh,E.H., Ke,H., Levine,A.J., Bonneau,R.A. and Chan,C.S.
  TITLE     Why are there hotspot mutations in the TP53 gene in human cancers?
  JOURNAL   Cell Death Differ 25 (1), 154-160 (2018)
   PUBMED   29099487
  REMARK    GeneRIF: TP53 missense mutant alleles that occur in human cancers
            are discussed in the context of high resolution models of these p53
            mutant protein structures to determine the structural features of
            mutations (review). Review article
REFERENCE   6  (bases 1 to 2629)
  AUTHORS   Aubrey,B.J., Strasser,A. and Kelly,G.L.
  TITLE     Tumor-Suppressor Functions of the TP53 Pathway
  JOURNAL   Cold Spring Harb Perspect Med 6 (5), a026062 (2016)
   PUBMED   27141080
  REMARK    Review article Publication Status: Online-Only
REFERENCE   7  (bases 1 to 2629)
  AUTHORS   Soussi,T. and Wiman,K.G.
  TITLE     TP53: an oncogene in disguise
  JOURNAL   Cell Death Differ 22 (8), 1239-1249 (2015)
   PUBMED   26024390
  REMARK    Review article
REFERENCE   8  (bases 1 to 2629)
  AUTHORS   Soussi,T.
  TITLE     The TP53 gene network in a postgenomic era
  JOURNAL   Hum Mutat 35 (6), 641-642 (2014)
   PUBMED   24753184
  REMARK    GeneRIF: Recommendations and guidelines for reporting and annotating
            TP53 variants are also provided, to help researchers generate
            standardized data that are easy to understand, analyze, and exchange
            across various cancer variant databases Review article
REFERENCE   9  (bases 1 to 2629)
  AUTHORS   Anczukow,O., Ware,M.D., Buisson,M., Zetoune,A.B., Stoppa-Lyonnet,D.,
            Sinilnikova,O.M. and Mazoyer,S.
  TITLE     Does the nonsense-mediated mRNA decay mechanism prevent the
            synthesis of truncated BRCA1, CHK2, and p53 proteins?
  JOURNAL   Hum Mutat 29 (1), 65-73 (2008)
   PUBMED   17694537
  REMARK    GeneRIF: the p53 protein encoded by the 770delT allele is as
            abundant as the wild-type protein, as removal of the C-terminal p53
            domain leads to a stabilized mutant protein, whose abundance is
            markedly increased when NMD is inhibited.
REFERENCE   10  (bases 1 to 2629)
  AUTHORS   Bourdon,J.C.
  TITLE     p53 Family isoforms
  JOURNAL   Curr Pharm Biotechnol 8 (6), 332-336 (2007)
   PUBMED   18289041
  REMARK    Review article
REFERENCE   11  (bases 1 to 2629)
  AUTHORS   Candeias,M.M., Powell,D.J., Roubalova,E., Apcher,S., Bourougaa,K.,
            Vojtesek,B., Bruzzoni-Giovanelli,H. and Fahraeus,R.
  TITLE     Expression of p53 and p53/47 are controlled by alternative
            mechanisms of messenger RNA translation initiation
  JOURNAL   Oncogene 25 (52), 6936-6947 (2006)
   PUBMED   16983332
  REMARK    GeneRIF: harbouring alternative translation initiation sites, the
            p53 mRNA gives rise to different levels of the p53 isoforms which
            help to orchestrate the cell biological outcome of p53 activation
REFERENCE   12  (bases 1 to 2629)
  AUTHORS   Murray-Zmijewski,F., Lane,D.P. and Bourdon,J.C.
  TITLE     p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell
            differentiation and response to stress
  JOURNAL   Cell Death Differ 13 (6), 962-972 (2006)
   PUBMED   16601753
  REMARK    Review article
REFERENCE   13  (bases 1 to 2629)
  AUTHORS   Bourdon,J.C., Fernandes,K., Murray-Zmijewski,F., Liu,G., Diot,A.,
            Xirodimas,D.P., Saville,M.K. and Lane,D.P.
  TITLE     p53 isoforms can regulate p53 transcriptional activity
  JOURNAL   Genes Dev 19 (18), 2122-2137 (2005)
   PUBMED   16131611
  REMARK    GeneRIF: p53 isoforms can regulate p53 transcriptional activity.
REFERENCE   14  (bases 1 to 2629)
  AUTHORS   Ghosh,A., Stewart,D. and Matlashewski,G.
  TITLE     Regulation of human p53 activity and cell localization by
            alternative splicing
  JOURNAL   Mol Cell Biol 24 (18), 7987-7997 (2004)
   PUBMED   15340061
  REMARK    GeneRIF: mechanism of p53 regulation originating through alternative
            splicing of the human p53 gene resulting in the expression of a
            novel p53 mRNA
REFERENCE   15  (bases 1 to 2629)
  AUTHORS   Flaman,J.M., Waridel,F., Estreicher,A., Vannier,A., Limacher,J.M.,
            Gilbert,D., Iggo,R. and Frebourg,T.
  TITLE     The human tumour suppressor gene p53 is alternatively spliced in
            normal cells
  JOURNAL   Oncogene 12 (4), 813-818 (1996)
   PUBMED   8632903
REFERENCE   16  (bases 1 to 2629)
  AUTHORS   Schneider,K., Zelley,K., Nichols,K.E., Schwartz Levine,A. and
            Garber,J.
  TITLE     Li-Fraumeni Syndrome
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE and Amemiya
            A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301488
REFERENCE   17  (bases 1 to 2629)
  AUTHORS   Turner,J.T., Brzezinski,J. and Dome,J.S.
  TITLE     Wilms Tumor Predisposition
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE and Amemiya
            A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301471
REFERENCE   18  (bases 1 to 2629)
  AUTHORS   Lamb,P. and Crawford,L.
  TITLE     Characterization of the human p53 gene
  JOURNAL   Mol Cell Biol 6 (5), 1379-1385 (1986)
   PUBMED   2946935
REFERENCE   19  (bases 1 to 2629)
  AUTHORS   Isobe,M., Emanuel,B.S., Givol,D., Oren,M. and Croce,C.M.
  TITLE     Localization of gene for human p53 tumour antigen to band 17p13
  JOURNAL   Nature 320 (6057), 84-85 (1986)
   PUBMED   3456488
REFERENCE   20  (bases 1 to 2629)
  AUTHORS   Benchimol,S., Lamb,P., Crawford,L.V., Sheer,D., Shows,T.B.,
            Bruns,G.A. and Peacock,J.
  TITLE     Transformation associated p53 protein is encoded by a gene on human
            chromosome 17
  JOURNAL   Somat Cell Mol Genet 11 (5), 505-510 (1985)
   PUBMED   2994241
REFERENCE   21  (bases 1 to 2629)
  AUTHORS   Harlow,E., Williamson,N.M., Ralston,R., Helfman,D.M. and Adams,T.E.
  TITLE     Molecular cloning and in vitro expression of a cDNA clone for human
            cellular tumor antigen p53
  JOURNAL   Mol Cell Biol 5 (7), 1601-1610 (1985)
   PUBMED   3894933
REFERENCE   22  (bases 1 to 2629)
  AUTHORS   Zakut-Houri,R., Bienz-Tadmor,B., Givol,D. and Oren,M.
  TITLE     Human p53 cellular tumor antigen: cDNA sequence and expression in
            COS cells
  JOURNAL   EMBO J 4 (5), 1251-1255 (1985)
   PUBMED   4006916
REFERENCE   23  (bases 1 to 2629)
  AUTHORS   Matlashewski,G., Lamb,P., Pim,D., Peacock,J., Crawford,L. and
            Benchimol,S.
  TITLE     Isolation and characterization of a human p53 cDNA clone: expression
            of the human p53 gene
  JOURNAL   EMBO J 3 (13), 3257-3262 (1984)
   PUBMED   6396087
COMMENT     ##Evidence-Data-START##
            Transcript exon combination :: JN900492.1, SRR11853567.12423.1
            [ECO:0000332]
            RNAseq introns :: mixed sample support SAMEA1965299, SAMEA1966682
            [ECO:0006172]
            ##Evidence-Data-END##
            REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from AC087388.9 and AC007421.13.
            On Aug 21, 2020 this sequence version replaced NM_001126118.1.
            Summary: This gene encodes a tumor suppressor protein containing
            transcriptional activation, DNA binding, and oligomerization
            domains. The encoded protein responds to diverse cellular stresses
            to regulate expression of target genes, thereby inducing cell cycle
            arrest, apoptosis, senescence, DNA repair, or changes in
            metabolism. Mutations in this gene are associated with a variety of
            human cancers, including hereditary cancers such as Li-Fraumeni
            syndrome. Alternative splicing of this gene and the use of
            alternate promoters result in multiple transcript variants and
            isoforms. Additional isoforms have also been shown to result from
            the use of alternate translation initiation codons from identical
            transcript variants (PMIDs: 12032546, 20937277). [provided by
            RefSeq, Dec 2016].
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            COMPLETENESS: full length.
FEATURES             Location/Qualifiers
     source          1..2629
                     /organism="Homo sapiens"
                     /mol_type="mRNA"
                     /db_xref="taxon:9606"
                     /chromosome="17"
                     /map="17p13.1"
     gene            1..2629
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="tumor protein p53"
                     /db_xref="GeneID:7157"
                     /db_xref="HGNC:HGNC:11998"
                     /db_xref="MIM:191170"
     exon            1..114
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            115..355
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     misc_feature    218..220
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="upstream in-frame stop codon"
     exon            356..634
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     CDS             377..1441
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="isoform g is encoded by transcript variant 8; tumor
                     protein 53; mutant tumor protein 53; cellular tumor antigen
                     p53; phosphoprotein p53; transformation-related protein 53;
                     antigen NY-CO-13; tumor supressor p53"
                     /codon_start=1
                     /product="cellular tumor antigen p53 isoform g"
                     /protein_id="NP_001119590.1"
                     /db_xref="CCDS:CCDS73969.1"
                     /db_xref="GeneID:7157"
                     /db_xref="HGNC:HGNC:11998"
                     /db_xref="MIM:191170"
                     /translation="MDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPAA
                     PAPAPSWPLSSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPV
                     QLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLR
                     VEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSS
                     GNLLGRNSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNTSSSPQPKK
                     KPLDGEYFTLQIRGRERFEMFRELNEALELKDAQAGKEPGGSRAHSSHLKSKKGQSTSR
                     HKKLMFKTEGPDSD"
     exon            635..818
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            819..931
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            932..1041
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            1042..1178
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            1179..1252
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            1253..1359
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            1360..2629
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     regulatory      2612..2617
                     /regulatory_class="polyA_signal_sequence"
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="hexamer: AATAAA"
     polyA_site      2629
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="major polyA site"
ORIGIN
        1 ctcaaaagtc tagagccacc gtccagggag caggtagctg ctgggctccg gggacacttt
       61 gcgttcgggc tgggagcgtg ctttccacga cggtgacacg cttccctgga ttggcagcca
      121 gactgccttc cgggtcactg ccatggagga gccgcagtca gatcctagcg tcgagccccc
      181 tctgagtcag gaaacatttt cagacctatg gaaactgtga gtggatccat tggaagggca
      241 ggcccaccac ccccacccca accccagccc cctagcagag acctgtggga agcgaaaatt
      301 ccatgggact gactttctgc tcttgtcttt cagacttcct gaaaacaacg ttctgtcccc
      361 cttgccgtcc caagcaatgg atgatttgat gctgtccccg gacgatattg aacaatggtt
      421 cactgaagac ccaggtccag atgaagctcc cagaatgcca gaggctgctc cccccgtggc
      481 ccctgcacca gcagctccta caccggcggc ccctgcacca gccccctcct ggcccctgtc
      541 atcttctgtc ccttcccaga aaacctacca gggcagctac ggtttccgtc tgggcttctt
      601 gcattctggg acagccaagt ctgtgacttg cacgtactcc cctgccctca acaagatgtt
      661 ttgccaactg gccaagacct gccctgtgca gctgtgggtt gattccacac ccccgcccgg
      721 cacccgcgtc cgcgccatgg ccatctacaa gcagtcacag cacatgacgg aggttgtgag
      781 gcgctgcccc caccatgagc gctgctcaga tagcgatggt ctggcccctc ctcagcatct
      841 tatccgagtg gaaggaaatt tgcgtgtgga gtatttggat gacagaaaca cttttcgaca
      901 tagtgtggtg gtgccctatg agccgcctga ggttggctct gactgtacca ccatccacta
      961 caactacatg tgtaacagtt cctgcatggg cggcatgaac cggaggccca tcctcaccat
     1021 catcacactg gaagactcca gtggtaatct actgggacgg aacagctttg aggtgcgtgt
     1081 ttgtgcctgt cctgggagag accggcgcac agaggaagag aatctccgca agaaagggga
     1141 gcctcaccac gagctgcccc cagggagcac taagcgagca ctgcccaaca acaccagctc
     1201 ctctccccag ccaaagaaga aaccactgga tggagaatat ttcacccttc agatccgtgg
     1261 gcgtgagcgc ttcgagatgt tccgagagct gaatgaggcc ttggaactca aggatgccca
     1321 ggctgggaag gagccagggg ggagcagggc tcactccagc cacctgaagt ccaaaaaggg
     1381 tcagtctacc tcccgccata aaaaactcat gttcaagaca gaagggcctg actcagactg
     1441 acattctcca cttcttgttc cccactgaca gcctcccacc cccatctctc cctcccctgc
     1501 cattttgggt tttgggtctt tgaacccttg cttgcaatag gtgtgcgtca gaagcaccca
     1561 ggacttccat ttgctttgtc ccggggctcc actgaacaag ttggcctgca ctggtgtttt
     1621 gttgtgggga ggaggatggg gagtaggaca taccagctta gattttaagg tttttactgt
     1681 gagggatgtt tgggagatgt aagaaatgtt cttgcagtta agggttagtt tacaatcagc
     1741 cacattctag gtaggggccc acttcaccgt actaaccagg gaagctgtcc ctcactgttg
     1801 aattttctct aacttcaagg cccatatctg tgaaatgctg gcatttgcac ctacctcaca
     1861 gagtgcattg tgagggttaa tgaaataatg tacatctggc cttgaaacca ccttttatta
     1921 catggggtct agaacttgac ccccttgagg gtgcttgttc cctctccctg ttggtcggtg
     1981 ggttggtagt ttctacagtt gggcagctgg ttaggtagag ggagttgtca agtctctgct
     2041 ggcccagcca aaccctgtct gacaacctct tggtgaacct tagtacctaa aaggaaatct
     2101 caccccatcc cacaccctgg aggatttcat ctcttgtata tgatgatctg gatccaccaa
     2161 gacttgtttt atgctcaggg tcaatttctt ttttcttttt tttttttttt tttctttttc
     2221 tttgagactg ggtctcgctt tgttgcccag gctggagtgg agtggcgtga tcttggctta
     2281 ctgcagcctt tgcctccccg gctcgagcag tcctgcctca gcctccggag tagctgggac
     2341 cacaggttca tgccaccatg gccagccaac ttttgcatgt tttgtagaga tggggtctca
     2401 cagtgttgcc caggctggtc tcaaactcct gggctcaggc gatccacctg tctcagcctc
     2461 ccagagtgct gggattacaa ttgtgagcca ccacgtccag ctggaagggt caacatcttt
     2521 tacattctgc aagcacatct gcattttcac cccacccttc ccctccttct ccctttttat
     2581 atcccatttt tatatcgatc tcttatttta caataaaact ttgctgcca
//
LOCUS       NM_001126112            2509 bp    mRNA    linear   PRI 12-JUN-2025
DEFINITION  Homo sapiens tumor protein p53 (TP53), transcript variant 2, mRNA.
ACCESSION   NM_001126112
VERSION     NM_001126112.3
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (bases 1 to 2509)
  AUTHORS   Mirgayazova,R., Khadiullina,R., Chasov,V., Mingaleeva,R.,
            Miftakhova,R., Rizvanov,A. and Bulatov,E.
  TITLE     Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option?
  JOURNAL   Genes (Basel) 11 (6), 704 (2020)
   PUBMED   32630614
  REMARK    GeneRIF: Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an
            Option? Review article Publication Status: Online-Only
REFERENCE   2  (bases 1 to 2509)
  AUTHORS   Flynt,E., Bisht,K., Sridharan,V., Ortiz,M., Towfic,F. and
            Thakurta,A.
  TITLE     Prognosis, Biology, and Targeting of TP53 Dysregulation in Multiple
            Myeloma
  JOURNAL   Cells 9 (2), 287 (2020)
   PUBMED   31991614
  REMARK    Review article Publication Status: Online-Only
REFERENCE   3  (bases 1 to 2509)
  AUTHORS   Barnoud,T., Parris,J.L.D. and Murphy,M.E.
  TITLE     Common genetic variants in the TP53 pathway and their impact on
            cancer
  JOURNAL   J Mol Cell Biol 11 (7), 578-585 (2019)
   PUBMED   31152665
  REMARK    GeneRIF: Common genetic variants in the TP53 pathway and their
            impact on cancer. Review article
REFERENCE   4  (bases 1 to 2509)
  AUTHORS   Hu,W., Chen,S., Thorne,R.F. and Wu,M.
  TITLE     TP53, TP53 Target Genes (DRAM, TIGAR), and Autophagy
  JOURNAL   Adv Exp Med Biol 1206, 127-149 (2019)
   PUBMED   31776983
  REMARK    Review article
REFERENCE   5  (bases 1 to 2509)
  AUTHORS   Baugh,E.H., Ke,H., Levine,A.J., Bonneau,R.A. and Chan,C.S.
  TITLE     Why are there hotspot mutations in the TP53 gene in human cancers?
  JOURNAL   Cell Death Differ 25 (1), 154-160 (2018)
   PUBMED   29099487
  REMARK    GeneRIF: TP53 missense mutant alleles that occur in human cancers
            are discussed in the context of high resolution models of these p53
            mutant protein structures to determine the structural features of
            mutations (review). Review article
REFERENCE   6  (bases 1 to 2509)
  AUTHORS   Aubrey,B.J., Strasser,A. and Kelly,G.L.
  TITLE     Tumor-Suppressor Functions of the TP53 Pathway
  JOURNAL   Cold Spring Harb Perspect Med 6 (5), a026062 (2016)
   PUBMED   27141080
  REMARK    Review article Publication Status: Online-Only
REFERENCE   7  (bases 1 to 2509)
  AUTHORS   Soussi,T. and Wiman,K.G.
  TITLE     TP53: an oncogene in disguise
  JOURNAL   Cell Death Differ 22 (8), 1239-1249 (2015)
   PUBMED   26024390
  REMARK    Review article
REFERENCE   8  (bases 1 to 2509)
  AUTHORS   Soussi,T.
  TITLE     The TP53 gene network in a postgenomic era
  JOURNAL   Hum Mutat 35 (6), 641-642 (2014)
   PUBMED   24753184
  REMARK    GeneRIF: Recommendations and guidelines for reporting and annotating
            TP53 variants are also provided, to help researchers generate
            standardized data that are easy to understand, analyze, and exchange
            across various cancer variant databases Review article
REFERENCE   9  (bases 1 to 2509)
  AUTHORS   Anczukow,O., Ware,M.D., Buisson,M., Zetoune,A.B., Stoppa-Lyonnet,D.,
            Sinilnikova,O.M. and Mazoyer,S.
  TITLE     Does the nonsense-mediated mRNA decay mechanism prevent the
            synthesis of truncated BRCA1, CHK2, and p53 proteins?
  JOURNAL   Hum Mutat 29 (1), 65-73 (2008)
   PUBMED   17694537
  REMARK    GeneRIF: the p53 protein encoded by the 770delT allele is as
            abundant as the wild-type protein, as removal of the C-terminal p53
            domain leads to a stabilized mutant protein, whose abundance is
            markedly increased when NMD is inhibited.
REFERENCE   10  (bases 1 to 2509)
  AUTHORS   Bourdon,J.C.
  TITLE     p53 Family isoforms
  JOURNAL   Curr Pharm Biotechnol 8 (6), 332-336 (2007)
   PUBMED   18289041
  REMARK    Review article
REFERENCE   11  (bases 1 to 2509)
  AUTHORS   Candeias,M.M., Powell,D.J., Roubalova,E., Apcher,S., Bourougaa,K.,
            Vojtesek,B., Bruzzoni-Giovanelli,H. and Fahraeus,R.
  TITLE     Expression of p53 and p53/47 are controlled by alternative
            mechanisms of messenger RNA translation initiation
  JOURNAL   Oncogene 25 (52), 6936-6947 (2006)
   PUBMED   16983332
  REMARK    GeneRIF: harbouring alternative translation initiation sites, the
            p53 mRNA gives rise to different levels of the p53 isoforms which
            help to orchestrate the cell biological outcome of p53 activation
REFERENCE   12  (bases 1 to 2509)
  AUTHORS   Murray-Zmijewski,F., Lane,D.P. and Bourdon,J.C.
  TITLE     p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell
            differentiation and response to stress
  JOURNAL   Cell Death Differ 13 (6), 962-972 (2006)
   PUBMED   16601753
  REMARK    Review article
REFERENCE   13  (bases 1 to 2509)
  AUTHORS   Bourdon,J.C., Fernandes,K., Murray-Zmijewski,F., Liu,G., Diot,A.,
            Xirodimas,D.P., Saville,M.K. and Lane,D.P.
  TITLE     p53 isoforms can regulate p53 transcriptional activity
  JOURNAL   Genes Dev 19 (18), 2122-2137 (2005)
   PUBMED   16131611
  REMARK    GeneRIF: p53 isoforms can regulate p53 transcriptional activity.
REFERENCE   14  (bases 1 to 2509)
  AUTHORS   Ghosh,A., Stewart,D. and Matlashewski,G.
  TITLE     Regulation of human p53 activity and cell localization by
            alternative splicing
  JOURNAL   Mol Cell Biol 24 (18), 7987-7997 (2004)
   PUBMED   15340061
  REMARK    GeneRIF: mechanism of p53 regulation originating through alternative
            splicing of the human p53 gene resulting in the expression of a
            novel p53 mRNA
REFERENCE   15  (bases 1 to 2509)
  AUTHORS   Flaman,J.M., Waridel,F., Estreicher,A., Vannier,A., Limacher,J.M.,
            Gilbert,D., Iggo,R. and Frebourg,T.
  TITLE     The human tumour suppressor gene p53 is alternatively spliced in
            normal cells
  JOURNAL   Oncogene 12 (4), 813-818 (1996)
   PUBMED   8632903
REFERENCE   16  (bases 1 to 2509)
  AUTHORS   Schneider,K., Zelley,K., Nichols,K.E., Schwartz Levine,A. and
            Garber,J.
  TITLE     Li-Fraumeni Syndrome
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE and Amemiya
            A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301488
REFERENCE   17  (bases 1 to 2509)
  AUTHORS   Turner,J.T., Brzezinski,J. and Dome,J.S.
  TITLE     Wilms Tumor Predisposition
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE and Amemiya
            A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301471
REFERENCE   18  (bases 1 to 2509)
  AUTHORS   Lamb,P. and Crawford,L.
  TITLE     Characterization of the human p53 gene
  JOURNAL   Mol Cell Biol 6 (5), 1379-1385 (1986)
   PUBMED   2946935
REFERENCE   19  (bases 1 to 2509)
  AUTHORS   Isobe,M., Emanuel,B.S., Givol,D., Oren,M. and Croce,C.M.
  TITLE     Localization of gene for human p53 tumour antigen to band 17p13
  JOURNAL   Nature 320 (6057), 84-85 (1986)
   PUBMED   3456488
REFERENCE   20  (bases 1 to 2509)
  AUTHORS   Benchimol,S., Lamb,P., Crawford,L.V., Sheer,D., Shows,T.B.,
            Bruns,G.A. and Peacock,J.
  TITLE     Transformation associated p53 protein is encoded by a gene on human
            chromosome 17
  JOURNAL   Somat Cell Mol Genet 11 (5), 505-510 (1985)
   PUBMED   2994241
REFERENCE   21  (bases 1 to 2509)
  AUTHORS   Harlow,E., Williamson,N.M., Ralston,R., Helfman,D.M. and Adams,T.E.
  TITLE     Molecular cloning and in vitro expression of a cDNA clone for human
            cellular tumor antigen p53
  JOURNAL   Mol Cell Biol 5 (7), 1601-1610 (1985)
   PUBMED   3894933
REFERENCE   22  (bases 1 to 2509)
  AUTHORS   Zakut-Houri,R., Bienz-Tadmor,B., Givol,D. and Oren,M.
  TITLE     Human p53 cellular tumor antigen: cDNA sequence and expression in
            COS cells
  JOURNAL   EMBO J 4 (5), 1251-1255 (1985)
   PUBMED   4006916
REFERENCE   23  (bases 1 to 2509)
  AUTHORS   Matlashewski,G., Lamb,P., Pim,D., Peacock,J., Crawford,L. and
            Benchimol,S.
  TITLE     Isolation and characterization of a human p53 cDNA clone: expression
            of the human p53 gene
  JOURNAL   EMBO J 3 (13), 3257-3262 (1984)
   PUBMED   6396087
COMMENT     ##Evidence-Data-START##
            Transcript exon combination :: AB082923.1, SRR14038194.3914132.1
            [ECO:0000332]
            RNAseq introns :: mixed sample support SAMEA1965299, SAMEA1966682
            [ECO:0006172]
            ##Evidence-Data-END##
            REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from AC087388.9 and AC007421.13.
            On Aug 21, 2020 this sequence version replaced NM_001126112.2.
            Summary: This gene encodes a tumor suppressor protein containing
            transcriptional activation, DNA binding, and oligomerization
            domains. The encoded protein responds to diverse cellular stresses
            to regulate expression of target genes, thereby inducing cell cycle
            arrest, apoptosis, senescence, DNA repair, or changes in
            metabolism. Mutations in this gene are associated with a variety of
            human cancers, including hereditary cancers such as Li-Fraumeni
            syndrome. Alternative splicing of this gene and the use of
            alternate promoters result in multiple transcript variants and
            isoforms. Additional isoforms have also been shown to result from
            the use of alternate translation initiation codons from identical
            transcript variants (PMIDs: 12032546, 20937277). [provided by
            RefSeq, Dec 2016].
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            COMPLETENESS: full length.
FEATURES             Location/Qualifiers
     source          1..2509
                     /organism="Homo sapiens"
                     /mol_type="mRNA"
                     /db_xref="taxon:9606"
                     /chromosome="17"
                     /map="17p13.1"
     gene            1..2509
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="tumor protein p53"
                     /db_xref="GeneID:7157"
                     /db_xref="HGNC:HGNC:11998"
                     /db_xref="MIM:191170"
     exon            1..114
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     misc_feature    35..37
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="upstream in-frame stop codon"
     exon            115..213
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     CDS             140..1321
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="isoform a is encoded by transcript variant 2; tumor
                     protein 53; mutant tumor protein 53; cellular tumor antigen
                     p53; phosphoprotein p53; transformation-related protein 53;
                     antigen NY-CO-13; tumor supressor p53"
                     /codon_start=1
                     /product="cellular tumor antigen p53 isoform a"
                     /protein_id="NP_001119584.1"
                     /db_xref="CCDS:CCDS11118.1"
                     /db_xref="GeneID:7157"
                     /db_xref="HGNC:HGNC:11998"
                     /db_xref="MIM:191170"
                     /translation="MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLML
                     SPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPAAPAPAPSWPLSSSVPSQKTYQ
                     GSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIY
                     KQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEP
                     PEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVRVCACPGRD
                     RRTEEENLRKKGEPHHELPPGSTKRALPNNTSSSPQPKKKPLDGEYFTLQIRGRERFEM
                     FRELNEALELKDAQAGKEPGGSRAHSSHLKSKKGQSTSRHKKLMFKTEGPDSD"
     misc_feature    140..1099
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Interaction with CCAR2.
                     /evidence=ECO:0000269|PubMed:25732823"
     misc_feature    140..388
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Interaction with HRMT1L2.
                     /evidence=ECO:0000269|PubMed:15186775"
     misc_feature    140..271
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Transcription activation (acidic)"
     misc_feature    164..166
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="Phosphoserine, by HIPK4.
                     /evidence=ECO:0000269|PubMed:18022393; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); phosphorylation site"
     misc_feature    182..184
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="Phosphoserine, by CDK5, PRPK, AMPK, NUAK1 and ATM.
                     /evidence=ECO:0000269|PubMed:10570149,
                     ECO:0000269|PubMed:11554766, ECO:0000269|PubMed:15866171,
                     ECO:0000269|PubMed:17108107, ECO:0000269|PubMed:17591690,
                     ECO:0000269|PubMed:17967874, ECO:0000269|PubMed:21317932,
                     ECO:0000269|PubMed:28842590; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); phosphorylation site"
     misc_feature    188..214
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: TADI"
     misc_feature    191..193
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="Phosphothreonine, by CK1, VRK1 and VRK2.
                     /evidence=ECO:0000269|PubMed:10606744,
                     ECO:0000269|PubMed:10951572, ECO:0000269|PubMed:16704422,
                     ECO:0000269|PubMed:31527692; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); phosphorylation site"
     misc_feature    197..199
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="Phosphoserine, by CHEK2, CK1 and PLK3.
                     /evidence=ECO:0000269|PubMed:10570149,
                     ECO:0000269|PubMed:11447225, ECO:0000269|PubMed:11551930,
                     ECO:0000269|PubMed:12810724, ECO:0000269|PubMed:20041275;
                     propagated from UniProtKB/Swiss-Prot (P04637.4);
                     phosphorylation site"
     misc_feature    236..238
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="Phosphoserine, by CDK5 and CDK7.
                     /evidence=ECO:0000269|PubMed:17591690,
                     ECO:0000269|PubMed:9372954; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); phosphorylation site"
     misc_feature    248..250
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="Phosphoserine, by MAPKAPK5.
                     /evidence=ECO:0000269|PubMed:17254968; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); phosphorylation site"
     misc_feature    257..259
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="delta40p53alpha; Region: alternative start codon"
     misc_feature    275..277
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="Phosphoserine, by CDK5, DYRK2, HIPK2 and PKC/PRKCG.
                     /evidence=ECO:0000269|PubMed:11740489,
                     ECO:0000269|PubMed:11780126, ECO:0000269|PubMed:16377624,
                     ECO:0000269|PubMed:17349958, ECO:0000269|PubMed:17591690;
                     propagated from UniProtKB/Swiss-Prot (P04637.4);
                     phosphorylation site"
     misc_feature    281..307
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: TADII"
     misc_feature    287..427
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Disordered. /evidence=ECO:0000269|PubMed:31953488"
     misc_feature    302..304
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="Phosphothreonine, by TAF1 and GRK5.
                     /evidence=ECO:0000269|PubMed:15053879,
                     ECO:0000269|PubMed:20124405; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); phosphorylation site"
     misc_feature    335..469
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Interaction with WWOX"
     misc_feature    437..1249
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Interaction with HIPK1. /evidence=ECO:0000250"
     misc_feature    437..1039
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Required for interaction with ZNF385A.
                     /evidence=ECO:0000269|PubMed:17719541"
     misc_feature    476..847
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Required for interaction with FBXO42.
                     /evidence=ECO:0000269|PubMed:19509332"
     misc_feature    485..1015
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Interaction with AXIN1. /evidence=ECO:0000250"
     misc_feature    497..499
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="Interaction with DNA.
                     /evidence=ECO:0000269|PubMed:16793544,
                     ECO:0000269|PubMed:18996393, ECO:0000269|PubMed:20364130;
                     propagated from UniProtKB/Swiss-Prot (P04637.4); other
                     site"
     misc_feature    497..499
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="N6-acetyllysine.
                     /evidence=ECO:0000269|PubMed:17189187,
                     ECO:0000269|PubMed:19854137, ECO:0000269|PubMed:23431171;
                     propagated from UniProtKB/Swiss-Prot (P04637.4);
                     acetylation site"
     misc_feature    686..688
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="Phosphoserine, by AURKB.
                     /evidence=ECO:0000269|PubMed:20959462; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); phosphorylation site"
     misc_feature    860..883
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Interaction with the 53BP2 SH3 domain"
     misc_feature    905..1021
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Interaction with E4F1.
                     /evidence=ECO:0000269|PubMed:10644996"
     misc_feature    944..946
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="Phosphoserine, by AURKB.
                     /evidence=ECO:0000269|PubMed:20959462; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); phosphorylation site"
     misc_feature    956..979
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Interaction with DNA"
     misc_feature    983..1114
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite"
     misc_feature    989..991
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="Phosphothreonine, by AURKB.
                     /evidence=ECO:0000269|PubMed:20959462; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); phosphorylation site"
     misc_feature    1037..1318
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Interaction with CARM1.
                     /evidence=ECO:0000269|PubMed:15186775"
     misc_feature    1052..1102
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Bipartite nuclear localization signal"
     misc_feature    1052..1054
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="N6-acetyllysine.
                     /evidence=ECO:0000269|PubMed:12724314; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); acetylation site"
     misc_feature    1082..1084
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="Phosphoserine, by AURKA, CDK1 and CDK2.
                     /evidence=ECO:0000269|PubMed:10884347,
                     ECO:0000269|PubMed:14702041; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); phosphorylation site"
     misc_feature    1094..1219
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Interaction with HIPK2"
     misc_feature    1100..1102
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="N6-acetyllysine.
                     /evidence=ECO:0000250|UniProtKB:P02340; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); acetylation site"
     misc_feature    1112..1207
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Oligomerization"
     misc_feature    1136..1138
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="Omega-N-methylarginine, by PRMT5.
                     /evidence=ECO:0000269|PubMed:19011621; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); methylation site"
     misc_feature    1142..1144
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="Symmetric dimethylarginine, by PRMT5.
                     /evidence=ECO:0000269|PubMed:19011621; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); methylation site"
     misc_feature    1148..1150
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="Symmetric dimethylarginine, by PRMT5.
                     /evidence=ECO:0000269|PubMed:19011621; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); methylation site"
     misc_feature    1154..1189
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Nuclear export signal"
     misc_feature    1190..1318
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Disordered. /evidence=ECO:0000269|PubMed:31953488,
                     ECO:0000269|PubMed:36108750"
     misc_feature    1214..1228
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Interaction with USP7"
     misc_feature    1241..1300
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Basic (repression of DNA-binding)"
     misc_feature    1247..1255
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: [KR]-[STA]-K motif"
     misc_feature    1247..1249
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="N6,N6-dimethyllysine, alternate.
                     /evidence=ECO:0000269|PubMed:17108971,
                     ECO:0000269|PubMed:22864287; N6-methyllysine, by SMYD2,
                     alternate. /evidence=ECO:0000269|PubMed:17108971,
                     ECO:0000269|PubMed:22864287; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); methylation site"
     misc_feature    1253..1255
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="N6-methyllysine, by SETD7.
                     /evidence=ECO:0000269|PubMed:15525938,
                     ECO:0000269|PubMed:16415881; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); methylation site"
     misc_feature    1256..1258
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="N6,N6-dimethyllysine, by EHMT1 and EHMT2, alternate.
                     /evidence=ECO:0000269|PubMed:20118233; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); methylation site"
     misc_feature    1256..1258
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="N6-acetyllysine, alternate.
                     /evidence=ECO:0000269|PubMed:10656795; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); acetylation site"
     misc_feature    1259..1318
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Interaction with MORN3.
                     /evidence=ECO:0000269|PubMed:29681526"
     misc_feature    1280..1282
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="N6-acetyllysine.
                     /evidence=ECO:0000269|PubMed:29474172,
                     ECO:0007744|PubMed:19608861; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); acetylation site"
     misc_feature    1283..1285
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="N6,N6-dimethyllysine, alternate.
                     /evidence=ECO:0000269|PubMed:17707234,
                     ECO:0000269|PubMed:20870725, ECO:0000269|PubMed:22864287;
                     N6-methyllysine, by KMT5A, alternate.
                     /evidence=ECO:0000269|PubMed:17707234,
                     ECO:0000269|PubMed:20870725, ECO:0000269|PubMed:22864287;
                     propagated from UniProtKB/Swiss-Prot (P04637.4);
                     methylation site"
     misc_feature    1283..1285
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="N6-acetyllysine, alternate.
                     /evidence=ECO:0000269|PubMed:10656795,
                     ECO:0000269|PubMed:15448695, ECO:0000269|PubMed:20228809,
                     ECO:0000269|PubMed:23431171, ECO:0000269|PubMed:29681526,
                     ECO:0007744|PubMed:19608861; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); acetylation site"
     misc_feature    1313..1315
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="Phosphoserine, by CK2, CDK2 and NUAK1.
                     /evidence=ECO:0000269|PubMed:10884347,
                     ECO:0000269|PubMed:11239457, ECO:0000269|PubMed:17108107,
                     ECO:0000269|PubMed:21317932, ECO:0000269|PubMed:22214662,
                     ECO:0000269|PubMed:35618207; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); phosphorylation site"
     exon            214..235
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            236..514
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            515..698
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            699..811
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            812..921
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            922..1058
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            1059..1132
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            1133..1239
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            1240..2509
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     regulatory      2492..2497
                     /regulatory_class="polyA_signal_sequence"
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="hexamer: AATAAA"
     polyA_site      2509
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="major polyA site"
ORIGIN
        1 ctcaaaagtc tagagccacc gtccagggag caggtagctg ctgggctccg gggacacttt
       61 gcgttcgggc tgggagcgtg ctttccacga cggtgacacg cttccctgga ttggccagac
      121 tgccttccgg gtcactgcca tggaggagcc gcagtcagat cctagcgtcg agccccctct
      181 gagtcaggaa acattttcag acctatggaa actacttcct gaaaacaacg ttctgtcccc
      241 cttgccgtcc caagcaatgg atgatttgat gctgtccccg gacgatattg aacaatggtt
      301 cactgaagac ccaggtccag atgaagctcc cagaatgcca gaggctgctc cccccgtggc
      361 ccctgcacca gcagctccta caccggcggc ccctgcacca gccccctcct ggcccctgtc
      421 atcttctgtc ccttcccaga aaacctacca gggcagctac ggtttccgtc tgggcttctt
      481 gcattctggg acagccaagt ctgtgacttg cacgtactcc cctgccctca acaagatgtt
      541 ttgccaactg gccaagacct gccctgtgca gctgtgggtt gattccacac ccccgcccgg
      601 cacccgcgtc cgcgccatgg ccatctacaa gcagtcacag cacatgacgg aggttgtgag
      661 gcgctgcccc caccatgagc gctgctcaga tagcgatggt ctggcccctc ctcagcatct
      721 tatccgagtg gaaggaaatt tgcgtgtgga gtatttggat gacagaaaca cttttcgaca
      781 tagtgtggtg gtgccctatg agccgcctga ggttggctct gactgtacca ccatccacta
      841 caactacatg tgtaacagtt cctgcatggg cggcatgaac cggaggccca tcctcaccat
      901 catcacactg gaagactcca gtggtaatct actgggacgg aacagctttg aggtgcgtgt
      961 ttgtgcctgt cctgggagag accggcgcac agaggaagag aatctccgca agaaagggga
     1021 gcctcaccac gagctgcccc cagggagcac taagcgagca ctgcccaaca acaccagctc
     1081 ctctccccag ccaaagaaga aaccactgga tggagaatat ttcacccttc agatccgtgg
     1141 gcgtgagcgc ttcgagatgt tccgagagct gaatgaggcc ttggaactca aggatgccca
     1201 ggctgggaag gagccagggg ggagcagggc tcactccagc cacctgaagt ccaaaaaggg
     1261 tcagtctacc tcccgccata aaaaactcat gttcaagaca gaagggcctg actcagactg
     1321 acattctcca cttcttgttc cccactgaca gcctcccacc cccatctctc cctcccctgc
     1381 cattttgggt tttgggtctt tgaacccttg cttgcaatag gtgtgcgtca gaagcaccca
     1441 ggacttccat ttgctttgtc ccggggctcc actgaacaag ttggcctgca ctggtgtttt
     1501 gttgtgggga ggaggatggg gagtaggaca taccagctta gattttaagg tttttactgt
     1561 gagggatgtt tgggagatgt aagaaatgtt cttgcagtta agggttagtt tacaatcagc
     1621 cacattctag gtaggggccc acttcaccgt actaaccagg gaagctgtcc ctcactgttg
     1681 aattttctct aacttcaagg cccatatctg tgaaatgctg gcatttgcac ctacctcaca
     1741 gagtgcattg tgagggttaa tgaaataatg tacatctggc cttgaaacca ccttttatta
     1801 catggggtct agaacttgac ccccttgagg gtgcttgttc cctctccctg ttggtcggtg
     1861 ggttggtagt ttctacagtt gggcagctgg ttaggtagag ggagttgtca agtctctgct
     1921 ggcccagcca aaccctgtct gacaacctct tggtgaacct tagtacctaa aaggaaatct
     1981 caccccatcc cacaccctgg aggatttcat ctcttgtata tgatgatctg gatccaccaa
     2041 gacttgtttt atgctcaggg tcaatttctt ttttcttttt tttttttttt tttctttttc
     2101 tttgagactg ggtctcgctt tgttgcccag gctggagtgg agtggcgtga tcttggctta
     2161 ctgcagcctt tgcctccccg gctcgagcag tcctgcctca gcctccggag tagctgggac
     2221 cacaggttca tgccaccatg gccagccaac ttttgcatgt tttgtagaga tggggtctca
     2281 cagtgttgcc caggctggtc tcaaactcct gggctcaggc gatccacctg tctcagcctc
     2341 ccagagtgct gggattacaa ttgtgagcca ccacgtccag ctggaagggt caacatcttt
     2401 tacattctgc aagcacatct gcattttcac cccacccttc ccctccttct ccctttttat
     2461 atcccatttt tatatcgatc tcttatttta caataaaact ttgctgcca
//
LOCUS       NM_001126116            2136 bp    mRNA    linear   PRI 12-JUN-2025
DEFINITION  Homo sapiens tumor protein p53 (TP53), transcript variant 6, mRNA.
ACCESSION   NM_001126116
VERSION     NM_001126116.2
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (bases 1 to 2136)
  AUTHORS   Mirgayazova,R., Khadiullina,R., Chasov,V., Mingaleeva,R.,
            Miftakhova,R., Rizvanov,A. and Bulatov,E.
  TITLE     Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option?
  JOURNAL   Genes (Basel) 11 (6), 704 (2020)
   PUBMED   32630614
  REMARK    GeneRIF: Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an
            Option? Review article Publication Status: Online-Only
REFERENCE   2  (bases 1 to 2136)
  AUTHORS   Flynt,E., Bisht,K., Sridharan,V., Ortiz,M., Towfic,F. and
            Thakurta,A.
  TITLE     Prognosis, Biology, and Targeting of TP53 Dysregulation in Multiple
            Myeloma
  JOURNAL   Cells 9 (2), 287 (2020)
   PUBMED   31991614
  REMARK    Review article Publication Status: Online-Only
REFERENCE   3  (bases 1 to 2136)
  AUTHORS   Barnoud,T., Parris,J.L.D. and Murphy,M.E.
  TITLE     Common genetic variants in the TP53 pathway and their impact on
            cancer
  JOURNAL   J Mol Cell Biol 11 (7), 578-585 (2019)
   PUBMED   31152665
  REMARK    GeneRIF: Common genetic variants in the TP53 pathway and their
            impact on cancer. Review article
REFERENCE   4  (bases 1 to 2136)
  AUTHORS   Hu,W., Chen,S., Thorne,R.F. and Wu,M.
  TITLE     TP53, TP53 Target Genes (DRAM, TIGAR), and Autophagy
  JOURNAL   Adv Exp Med Biol 1206, 127-149 (2019)
   PUBMED   31776983
  REMARK    Review article
REFERENCE   5  (bases 1 to 2136)
  AUTHORS   Baugh,E.H., Ke,H., Levine,A.J., Bonneau,R.A. and Chan,C.S.
  TITLE     Why are there hotspot mutations in the TP53 gene in human cancers?
  JOURNAL   Cell Death Differ 25 (1), 154-160 (2018)
   PUBMED   29099487
  REMARK    GeneRIF: TP53 missense mutant alleles that occur in human cancers
            are discussed in the context of high resolution models of these p53
            mutant protein structures to determine the structural features of
            mutations (review). Review article
REFERENCE   6  (bases 1 to 2136)
  AUTHORS   Aubrey,B.J., Strasser,A. and Kelly,G.L.
  TITLE     Tumor-Suppressor Functions of the TP53 Pathway
  JOURNAL   Cold Spring Harb Perspect Med 6 (5), a026062 (2016)
   PUBMED   27141080
  REMARK    Review article Publication Status: Online-Only
REFERENCE   7  (bases 1 to 2136)
  AUTHORS   Soussi,T. and Wiman,K.G.
  TITLE     TP53: an oncogene in disguise
  JOURNAL   Cell Death Differ 22 (8), 1239-1249 (2015)
   PUBMED   26024390
  REMARK    Review article
REFERENCE   8  (bases 1 to 2136)
  AUTHORS   Soussi,T.
  TITLE     The TP53 gene network in a postgenomic era
  JOURNAL   Hum Mutat 35 (6), 641-642 (2014)
   PUBMED   24753184
  REMARK    GeneRIF: Recommendations and guidelines for reporting and annotating
            TP53 variants are also provided, to help researchers generate
            standardized data that are easy to understand, analyze, and exchange
            across various cancer variant databases Review article
REFERENCE   9  (bases 1 to 2136)
  AUTHORS   Anczukow,O., Ware,M.D., Buisson,M., Zetoune,A.B., Stoppa-Lyonnet,D.,
            Sinilnikova,O.M. and Mazoyer,S.
  TITLE     Does the nonsense-mediated mRNA decay mechanism prevent the
            synthesis of truncated BRCA1, CHK2, and p53 proteins?
  JOURNAL   Hum Mutat 29 (1), 65-73 (2008)
   PUBMED   17694537
  REMARK    GeneRIF: the p53 protein encoded by the 770delT allele is as
            abundant as the wild-type protein, as removal of the C-terminal p53
            domain leads to a stabilized mutant protein, whose abundance is
            markedly increased when NMD is inhibited.
REFERENCE   10  (bases 1 to 2136)
  AUTHORS   Bourdon,J.C.
  TITLE     p53 Family isoforms
  JOURNAL   Curr Pharm Biotechnol 8 (6), 332-336 (2007)
   PUBMED   18289041
  REMARK    Review article
REFERENCE   11  (bases 1 to 2136)
  AUTHORS   Candeias,M.M., Powell,D.J., Roubalova,E., Apcher,S., Bourougaa,K.,
            Vojtesek,B., Bruzzoni-Giovanelli,H. and Fahraeus,R.
  TITLE     Expression of p53 and p53/47 are controlled by alternative
            mechanisms of messenger RNA translation initiation
  JOURNAL   Oncogene 25 (52), 6936-6947 (2006)
   PUBMED   16983332
  REMARK    GeneRIF: harbouring alternative translation initiation sites, the
            p53 mRNA gives rise to different levels of the p53 isoforms which
            help to orchestrate the cell biological outcome of p53 activation
REFERENCE   12  (bases 1 to 2136)
  AUTHORS   Murray-Zmijewski,F., Lane,D.P. and Bourdon,J.C.
  TITLE     p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell
            differentiation and response to stress
  JOURNAL   Cell Death Differ 13 (6), 962-972 (2006)
   PUBMED   16601753
  REMARK    Review article
REFERENCE   13  (bases 1 to 2136)
  AUTHORS   Bourdon,J.C., Fernandes,K., Murray-Zmijewski,F., Liu,G., Diot,A.,
            Xirodimas,D.P., Saville,M.K. and Lane,D.P.
  TITLE     p53 isoforms can regulate p53 transcriptional activity
  JOURNAL   Genes Dev 19 (18), 2122-2137 (2005)
   PUBMED   16131611
  REMARK    GeneRIF: p53 isoforms can regulate p53 transcriptional activity.
REFERENCE   14  (bases 1 to 2136)
  AUTHORS   Ghosh,A., Stewart,D. and Matlashewski,G.
  TITLE     Regulation of human p53 activity and cell localization by
            alternative splicing
  JOURNAL   Mol Cell Biol 24 (18), 7987-7997 (2004)
   PUBMED   15340061
  REMARK    GeneRIF: mechanism of p53 regulation originating through alternative
            splicing of the human p53 gene resulting in the expression of a
            novel p53 mRNA
REFERENCE   15  (bases 1 to 2136)
  AUTHORS   Flaman,J.M., Waridel,F., Estreicher,A., Vannier,A., Limacher,J.M.,
            Gilbert,D., Iggo,R. and Frebourg,T.
  TITLE     The human tumour suppressor gene p53 is alternatively spliced in
            normal cells
  JOURNAL   Oncogene 12 (4), 813-818 (1996)
   PUBMED   8632903
REFERENCE   16  (bases 1 to 2136)
  AUTHORS   Schneider,K., Zelley,K., Nichols,K.E., Schwartz Levine,A. and
            Garber,J.
  TITLE     Li-Fraumeni Syndrome
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE and Amemiya
            A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301488
REFERENCE   17  (bases 1 to 2136)
  AUTHORS   Turner,J.T., Brzezinski,J. and Dome,J.S.
  TITLE     Wilms Tumor Predisposition
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE and Amemiya
            A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301471
REFERENCE   18  (bases 1 to 2136)
  AUTHORS   Lamb,P. and Crawford,L.
  TITLE     Characterization of the human p53 gene
  JOURNAL   Mol Cell Biol 6 (5), 1379-1385 (1986)
   PUBMED   2946935
REFERENCE   19  (bases 1 to 2136)
  AUTHORS   Isobe,M., Emanuel,B.S., Givol,D., Oren,M. and Croce,C.M.
  TITLE     Localization of gene for human p53 tumour antigen to band 17p13
  JOURNAL   Nature 320 (6057), 84-85 (1986)
   PUBMED   3456488
REFERENCE   20  (bases 1 to 2136)
  AUTHORS   Benchimol,S., Lamb,P., Crawford,L.V., Sheer,D., Shows,T.B.,
            Bruns,G.A. and Peacock,J.
  TITLE     Transformation associated p53 protein is encoded by a gene on human
            chromosome 17
  JOURNAL   Somat Cell Mol Genet 11 (5), 505-510 (1985)
   PUBMED   2994241
REFERENCE   21  (bases 1 to 2136)
  AUTHORS   Harlow,E., Williamson,N.M., Ralston,R., Helfman,D.M. and Adams,T.E.
  TITLE     Molecular cloning and in vitro expression of a cDNA clone for human
            cellular tumor antigen p53
  JOURNAL   Mol Cell Biol 5 (7), 1601-1610 (1985)
   PUBMED   3894933
REFERENCE   22  (bases 1 to 2136)
  AUTHORS   Zakut-Houri,R., Bienz-Tadmor,B., Givol,D. and Oren,M.
  TITLE     Human p53 cellular tumor antigen: cDNA sequence and expression in
            COS cells
  JOURNAL   EMBO J 4 (5), 1251-1255 (1985)
   PUBMED   4006916
REFERENCE   23  (bases 1 to 2136)
  AUTHORS   Matlashewski,G., Lamb,P., Pim,D., Peacock,J., Crawford,L. and
            Benchimol,S.
  TITLE     Isolation and characterization of a human p53 cDNA clone: expression
            of the human p53 gene
  JOURNAL   EMBO J 3 (13), 3257-3262 (1984)
   PUBMED   6396087
COMMENT     ##Evidence-Data-START##
            Transcript exon combination :: DQ186651.1, SRR14038191.875793.1
            [ECO:0000332]
            RNAseq introns :: mixed sample support SAMEA1965299, SAMEA1966682
            [ECO:0006172]
            ##Evidence-Data-END##
            ##RefSeq-Attributes-START##
            NMD candidate               :: PMID: 16131611, 16601753, 18289041
            ##RefSeq-Attributes-END##
            REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from AC087388.9 and AC007421.13.
            On Aug 21, 2020 this sequence version replaced NM_001126116.1.
            Summary: This gene encodes a tumor suppressor protein containing
            transcriptional activation, DNA binding, and oligomerization
            domains. The encoded protein responds to diverse cellular stresses
            to regulate expression of target genes, thereby inducing cell cycle
            arrest, apoptosis, senescence, DNA repair, or changes in
            metabolism. Mutations in this gene are associated with a variety of
            human cancers, including hereditary cancers such as Li-Fraumeni
            syndrome. Alternative splicing of this gene and the use of
            alternate promoters result in multiple transcript variants and
            isoforms. Additional isoforms have also been shown to result from
            the use of alternate translation initiation codons from identical
            transcript variants (PMIDs: 12032546, 20937277). [provided by
            RefSeq, Dec 2016].
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            COMPLETENESS: full length.
FEATURES             Location/Qualifiers
     source          1..2136
                     /organism="Homo sapiens"
                     /mol_type="mRNA"
                     /db_xref="taxon:9606"
                     /chromosome="17"
                     /map="17p13.1"
     gene            1..2136
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="tumor protein p53"
                     /db_xref="GeneID:7157"
                     /db_xref="HGNC:HGNC:11998"
                     /db_xref="MIM:191170"
     exon            1..192
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     CDS             30..659
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="isoform e is encoded by transcript variant 6; tumor
                     protein 53; mutant tumor protein 53; cellular tumor antigen
                     p53; phosphoprotein p53; transformation-related protein 53;
                     antigen NY-CO-13; tumor supressor p53"
                     /codon_start=1
                     /product="cellular tumor antigen p53 isoform e"
                     /protein_id="NP_001119588.1"
                     /db_xref="CCDS:CCDS73968.1"
                     /db_xref="GeneID:7157"
                     /db_xref="HGNC:HGNC:11998"
                     /db_xref="MIM:191170"
                     /translation="MFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCP
                     HHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNY
                     MCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVRVCACPGRDRRTEEENLRKKGEP
                     HHELPPGSTKRALPNNTSSSPQPKKKPLDGEYFTLQDQTSFQKENC"
     misc_feature    111..113
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="delta160p53beta; Region: alternative start codon"
     exon            193..305
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            306..415
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            416..552
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            553..626
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            627..759
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            760..866
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            867..2136
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     regulatory      2119..2124
                     /regulatory_class="polyA_signal_sequence"
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="hexamer: AATAAA"
     polyA_site      2136
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="major polyA site"
ORIGIN
        1 tcctacagta ctcccctgcc ctcaacaaga tgttttgcca actggccaag acctgccctg
       61 tgcagctgtg ggttgattcc acacccccgc ccggcacccg cgtccgcgcc atggccatct
      121 acaagcagtc acagcacatg acggaggttg tgaggcgctg cccccaccat gagcgctgct
      181 cagatagcga tggtctggcc cctcctcagc atcttatccg agtggaagga aatttgcgtg
      241 tggagtattt ggatgacaga aacacttttc gacatagtgt ggtggtgccc tatgagccgc
      301 ctgaggttgg ctctgactgt accaccatcc actacaacta catgtgtaac agttcctgca
      361 tgggcggcat gaaccggagg cccatcctca ccatcatcac actggaagac tccagtggta
      421 atctactggg acggaacagc tttgaggtgc gtgtttgtgc ctgtcctggg agagaccggc
      481 gcacagagga agagaatctc cgcaagaaag gggagcctca ccacgagctg cccccaggga
      541 gcactaagcg agcactgccc aacaacacca gctcctctcc ccagccaaag aagaaaccac
      601 tggatggaga atatttcacc cttcaggacc agaccagctt tcaaaaagaa aattgttaaa
      661 gagagcatga aaatggttct atgactttgc ctgatacaga tgctacttga cttacgatgg
      721 tgttacttcc tgataaactc gtcgtaagtt gaaaatatta tccgtgggcg tgagcgcttc
      781 gagatgttcc gagagctgaa tgaggccttg gaactcaagg atgcccaggc tgggaaggag
      841 ccagggggga gcagggctca ctccagccac ctgaagtcca aaaagggtca gtctacctcc
      901 cgccataaaa aactcatgtt caagacagaa gggcctgact cagactgaca ttctccactt
      961 cttgttcccc actgacagcc tcccaccccc atctctccct cccctgccat tttgggtttt
     1021 gggtctttga acccttgctt gcaataggtg tgcgtcagaa gcacccagga cttccatttg
     1081 ctttgtcccg gggctccact gaacaagttg gcctgcactg gtgttttgtt gtggggagga
     1141 ggatggggag taggacatac cagcttagat tttaaggttt ttactgtgag ggatgtttgg
     1201 gagatgtaag aaatgttctt gcagttaagg gttagtttac aatcagccac attctaggta
     1261 ggggcccact tcaccgtact aaccagggaa gctgtccctc actgttgaat tttctctaac
     1321 ttcaaggccc atatctgtga aatgctggca tttgcaccta cctcacagag tgcattgtga
     1381 gggttaatga aataatgtac atctggcctt gaaaccacct tttattacat ggggtctaga
     1441 acttgacccc cttgagggtg cttgttccct ctccctgttg gtcggtgggt tggtagtttc
     1501 tacagttggg cagctggtta ggtagaggga gttgtcaagt ctctgctggc ccagccaaac
     1561 cctgtctgac aacctcttgg tgaaccttag tacctaaaag gaaatctcac cccatcccac
     1621 accctggagg atttcatctc ttgtatatga tgatctggat ccaccaagac ttgttttatg
     1681 ctcagggtca atttcttttt tctttttttt tttttttttt ctttttcttt gagactgggt
     1741 ctcgctttgt tgcccaggct ggagtggagt ggcgtgatct tggcttactg cagcctttgc
     1801 ctccccggct cgagcagtcc tgcctcagcc tccggagtag ctgggaccac aggttcatgc
     1861 caccatggcc agccaacttt tgcatgtttt gtagagatgg ggtctcacag tgttgcccag
     1921 gctggtctca aactcctggg ctcaggcgat ccacctgtct cagcctccca gagtgctggg
     1981 attacaattg tgagccacca cgtccagctg gaagggtcaa catcttttac attctgcaag
     2041 cacatctgca ttttcacccc acccttcccc tccttctccc tttttatatc ccatttttat
     2101 atcgatctct tattttacaa taaaactttg ctgcca
//
LOCUS       NM_001126113            2572 bp    mRNA    linear   PRI 12-JUN-2025
DEFINITION  Homo sapiens tumor protein p53 (TP53), transcript variant 4, mRNA.
ACCESSION   NM_001126113
VERSION     NM_001126113.3
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (bases 1 to 2572)
  AUTHORS   Mirgayazova,R., Khadiullina,R., Chasov,V., Mingaleeva,R.,
            Miftakhova,R., Rizvanov,A. and Bulatov,E.
  TITLE     Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option?
  JOURNAL   Genes (Basel) 11 (6), 704 (2020)
   PUBMED   32630614
  REMARK    GeneRIF: Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an
            Option? Review article Publication Status: Online-Only
REFERENCE   2  (bases 1 to 2572)
  AUTHORS   Flynt,E., Bisht,K., Sridharan,V., Ortiz,M., Towfic,F. and
            Thakurta,A.
  TITLE     Prognosis, Biology, and Targeting of TP53 Dysregulation in Multiple
            Myeloma
  JOURNAL   Cells 9 (2), 287 (2020)
   PUBMED   31991614
  REMARK    Review article Publication Status: Online-Only
REFERENCE   3  (bases 1 to 2572)
  AUTHORS   Barnoud,T., Parris,J.L.D. and Murphy,M.E.
  TITLE     Common genetic variants in the TP53 pathway and their impact on
            cancer
  JOURNAL   J Mol Cell Biol 11 (7), 578-585 (2019)
   PUBMED   31152665
  REMARK    GeneRIF: Common genetic variants in the TP53 pathway and their
            impact on cancer. Review article
REFERENCE   4  (bases 1 to 2572)
  AUTHORS   Hu,W., Chen,S., Thorne,R.F. and Wu,M.
  TITLE     TP53, TP53 Target Genes (DRAM, TIGAR), and Autophagy
  JOURNAL   Adv Exp Med Biol 1206, 127-149 (2019)
   PUBMED   31776983
  REMARK    Review article
REFERENCE   5  (bases 1 to 2572)
  AUTHORS   Baugh,E.H., Ke,H., Levine,A.J., Bonneau,R.A. and Chan,C.S.
  TITLE     Why are there hotspot mutations in the TP53 gene in human cancers?
  JOURNAL   Cell Death Differ 25 (1), 154-160 (2018)
   PUBMED   29099487
  REMARK    GeneRIF: TP53 missense mutant alleles that occur in human cancers
            are discussed in the context of high resolution models of these p53
            mutant protein structures to determine the structural features of
            mutations (review). Review article
REFERENCE   6  (bases 1 to 2572)
  AUTHORS   Aubrey,B.J., Strasser,A. and Kelly,G.L.
  TITLE     Tumor-Suppressor Functions of the TP53 Pathway
  JOURNAL   Cold Spring Harb Perspect Med 6 (5), a026062 (2016)
   PUBMED   27141080
  REMARK    Review article Publication Status: Online-Only
REFERENCE   7  (bases 1 to 2572)
  AUTHORS   Soussi,T. and Wiman,K.G.
  TITLE     TP53: an oncogene in disguise
  JOURNAL   Cell Death Differ 22 (8), 1239-1249 (2015)
   PUBMED   26024390
  REMARK    Review article
REFERENCE   8  (bases 1 to 2572)
  AUTHORS   Soussi,T.
  TITLE     The TP53 gene network in a postgenomic era
  JOURNAL   Hum Mutat 35 (6), 641-642 (2014)
   PUBMED   24753184
  REMARK    GeneRIF: Recommendations and guidelines for reporting and annotating
            TP53 variants are also provided, to help researchers generate
            standardized data that are easy to understand, analyze, and exchange
            across various cancer variant databases Review article
REFERENCE   9  (bases 1 to 2572)
  AUTHORS   Anczukow,O., Ware,M.D., Buisson,M., Zetoune,A.B., Stoppa-Lyonnet,D.,
            Sinilnikova,O.M. and Mazoyer,S.
  TITLE     Does the nonsense-mediated mRNA decay mechanism prevent the
            synthesis of truncated BRCA1, CHK2, and p53 proteins?
  JOURNAL   Hum Mutat 29 (1), 65-73 (2008)
   PUBMED   17694537
  REMARK    GeneRIF: the p53 protein encoded by the 770delT allele is as
            abundant as the wild-type protein, as removal of the C-terminal p53
            domain leads to a stabilized mutant protein, whose abundance is
            markedly increased when NMD is inhibited.
REFERENCE   10  (bases 1 to 2572)
  AUTHORS   Bourdon,J.C.
  TITLE     p53 Family isoforms
  JOURNAL   Curr Pharm Biotechnol 8 (6), 332-336 (2007)
   PUBMED   18289041
  REMARK    Review article
REFERENCE   11  (bases 1 to 2572)
  AUTHORS   Candeias,M.M., Powell,D.J., Roubalova,E., Apcher,S., Bourougaa,K.,
            Vojtesek,B., Bruzzoni-Giovanelli,H. and Fahraeus,R.
  TITLE     Expression of p53 and p53/47 are controlled by alternative
            mechanisms of messenger RNA translation initiation
  JOURNAL   Oncogene 25 (52), 6936-6947 (2006)
   PUBMED   16983332
  REMARK    GeneRIF: harbouring alternative translation initiation sites, the
            p53 mRNA gives rise to different levels of the p53 isoforms which
            help to orchestrate the cell biological outcome of p53 activation
REFERENCE   12  (bases 1 to 2572)
  AUTHORS   Murray-Zmijewski,F., Lane,D.P. and Bourdon,J.C.
  TITLE     p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell
            differentiation and response to stress
  JOURNAL   Cell Death Differ 13 (6), 962-972 (2006)
   PUBMED   16601753
  REMARK    Review article
REFERENCE   13  (bases 1 to 2572)
  AUTHORS   Bourdon,J.C., Fernandes,K., Murray-Zmijewski,F., Liu,G., Diot,A.,
            Xirodimas,D.P., Saville,M.K. and Lane,D.P.
  TITLE     p53 isoforms can regulate p53 transcriptional activity
  JOURNAL   Genes Dev 19 (18), 2122-2137 (2005)
   PUBMED   16131611
  REMARK    GeneRIF: p53 isoforms can regulate p53 transcriptional activity.
REFERENCE   14  (bases 1 to 2572)
  AUTHORS   Ghosh,A., Stewart,D. and Matlashewski,G.
  TITLE     Regulation of human p53 activity and cell localization by
            alternative splicing
  JOURNAL   Mol Cell Biol 24 (18), 7987-7997 (2004)
   PUBMED   15340061
  REMARK    GeneRIF: mechanism of p53 regulation originating through alternative
            splicing of the human p53 gene resulting in the expression of a
            novel p53 mRNA
REFERENCE   15  (bases 1 to 2572)
  AUTHORS   Flaman,J.M., Waridel,F., Estreicher,A., Vannier,A., Limacher,J.M.,
            Gilbert,D., Iggo,R. and Frebourg,T.
  TITLE     The human tumour suppressor gene p53 is alternatively spliced in
            normal cells
  JOURNAL   Oncogene 12 (4), 813-818 (1996)
   PUBMED   8632903
REFERENCE   16  (bases 1 to 2572)
  AUTHORS   Schneider,K., Zelley,K., Nichols,K.E., Schwartz Levine,A. and
            Garber,J.
  TITLE     Li-Fraumeni Syndrome
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE and Amemiya
            A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301488
REFERENCE   17  (bases 1 to 2572)
  AUTHORS   Turner,J.T., Brzezinski,J. and Dome,J.S.
  TITLE     Wilms Tumor Predisposition
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE and Amemiya
            A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301471
REFERENCE   18  (bases 1 to 2572)
  AUTHORS   Lamb,P. and Crawford,L.
  TITLE     Characterization of the human p53 gene
  JOURNAL   Mol Cell Biol 6 (5), 1379-1385 (1986)
   PUBMED   2946935
REFERENCE   19  (bases 1 to 2572)
  AUTHORS   Isobe,M., Emanuel,B.S., Givol,D., Oren,M. and Croce,C.M.
  TITLE     Localization of gene for human p53 tumour antigen to band 17p13
  JOURNAL   Nature 320 (6057), 84-85 (1986)
   PUBMED   3456488
REFERENCE   20  (bases 1 to 2572)
  AUTHORS   Benchimol,S., Lamb,P., Crawford,L.V., Sheer,D., Shows,T.B.,
            Bruns,G.A. and Peacock,J.
  TITLE     Transformation associated p53 protein is encoded by a gene on human
            chromosome 17
  JOURNAL   Somat Cell Mol Genet 11 (5), 505-510 (1985)
   PUBMED   2994241
REFERENCE   21  (bases 1 to 2572)
  AUTHORS   Harlow,E., Williamson,N.M., Ralston,R., Helfman,D.M. and Adams,T.E.
  TITLE     Molecular cloning and in vitro expression of a cDNA clone for human
            cellular tumor antigen p53
  JOURNAL   Mol Cell Biol 5 (7), 1601-1610 (1985)
   PUBMED   3894933
REFERENCE   22  (bases 1 to 2572)
  AUTHORS   Zakut-Houri,R., Bienz-Tadmor,B., Givol,D. and Oren,M.
  TITLE     Human p53 cellular tumor antigen: cDNA sequence and expression in
            COS cells
  JOURNAL   EMBO J 4 (5), 1251-1255 (1985)
   PUBMED   4006916
REFERENCE   23  (bases 1 to 2572)
  AUTHORS   Matlashewski,G., Lamb,P., Pim,D., Peacock,J., Crawford,L. and
            Benchimol,S.
  TITLE     Isolation and characterization of a human p53 cDNA clone: expression
            of the human p53 gene
  JOURNAL   EMBO J 3 (13), 3257-3262 (1984)
   PUBMED   6396087
COMMENT     ##Evidence-Data-START##
            Transcript exon combination :: DQ186649.1 [ECO:0000332]
            RNAseq introns :: mixed sample support SAMEA1965299, SAMEA1966682
            [ECO:0006172]
            ##Evidence-Data-END##
            ##RefSeq-Attributes-START##
            NMD candidate               :: translation inferred
            ##RefSeq-Attributes-END##
            REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from AC087388.9 and AC007421.13.
            On Aug 21, 2020 this sequence version replaced NM_001126113.2.
            Summary: This gene encodes a tumor suppressor protein containing
            transcriptional activation, DNA binding, and oligomerization
            domains. The encoded protein responds to diverse cellular stresses
            to regulate expression of target genes, thereby inducing cell cycle
            arrest, apoptosis, senescence, DNA repair, or changes in
            metabolism. Mutations in this gene are associated with a variety of
            human cancers, including hereditary cancers such as Li-Fraumeni
            syndrome. Alternative splicing of this gene and the use of
            alternate promoters result in multiple transcript variants and
            isoforms. Additional isoforms have also been shown to result from
            the use of alternate translation initiation codons from identical
            transcript variants (PMIDs: 12032546, 20937277). [provided by
            RefSeq, Dec 2016].
            CCDS Note: This CCDS ID represents the p53gamma isoform described
            in PMIDs: 16131611, 16601753 and 18289041. This variant is
            supported by the transcript DQ186649.1. It should be noted that
            this transcript is predicted to undergo nonsense-mediated mRNA
            decay (NMD). However, the protein is represented because other
            similar isoforms derived from NMD transcripts were detected
            endogenously in PMID:16131611. In addition, experiments in
            PMID:17694537 indicate that this gene may be somewhat less
            sensitive to NMD. A contributing factor is the presence of a
            ubiquitination domain in the C-terminus of the full-length protein,
            which makes the protein less stable under non-stress conditions.
            C-terminally truncated proteins that lack the ubiquitination
            domain, such as this isoform, are therefore more stable. NMD
            inhibition experiments in the same study show that the majority of
            NMD transcripts do indeed undergo NMD, but some low level of NMD
            escape, combined with the increased stability of C-terminally
            truncated isoforms, allows for the expression of such isoforms.
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            COMPLETENESS: full length.
FEATURES             Location/Qualifiers
     source          1..2572
                     /organism="Homo sapiens"
                     /mol_type="mRNA"
                     /db_xref="taxon:9606"
                     /chromosome="17"
                     /map="17p13.1"
     gene            1..2572
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="tumor protein p53"
                     /db_xref="GeneID:7157"
                     /db_xref="HGNC:HGNC:11998"
                     /db_xref="MIM:191170"
     exon            1..114
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     misc_feature    35..37
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="upstream in-frame stop codon"
     exon            115..216
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     CDS             143..1183
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="isoform c is encoded by transcript variant 4; tumor
                     protein 53; mutant tumor protein 53; cellular tumor antigen
                     p53; phosphoprotein p53; transformation-related protein 53;
                     antigen NY-CO-13; tumor supressor p53"
                     /codon_start=1
                     /product="cellular tumor antigen p53 isoform c"
                     /protein_id="NP_001119585.1"
                     /db_xref="CCDS:CCDS45605.1"
                     /db_xref="GeneID:7157"
                     /db_xref="HGNC:HGNC:11998"
                     /db_xref="MIM:191170"
                     /translation="MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLML
                     SPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPAAPAPAPSWPLSSSVPSQKTYQ
                     GSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIY
                     KQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEP
                     PEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVRVCACPGRD
                     RRTEEENLRKKGEPHHELPPGSTKRALPNNTSSSPQPKKKPLDGEYFTLQMLLDLRWCY
                     FLINSS"
     misc_feature    260..262
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="delta40p53gamma; Region: alternative start codon"
     exon            217..238
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            239..517
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            518..701
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            702..814
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            815..924
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            925..1061
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            1062..1135
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            1136..1195
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            1196..1302
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            1303..2572
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     regulatory      2555..2560
                     /regulatory_class="polyA_signal_sequence"
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="hexamer: AATAAA"
     polyA_site      2572
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="major polyA site"
ORIGIN
        1 ctcaaaagtc tagagccacc gtccagggag caggtagctg ctgggctccg gggacacttt
       61 gcgttcgggc tgggagcgtg ctttccacga cggtgacacg cttccctgga ttggcagcca
      121 gactgccttc cgggtcactg ccatggagga gccgcagtca gatcctagcg tcgagccccc
      181 tctgagtcag gaaacatttt cagacctatg gaaactactt cctgaaaaca acgttctgtc
      241 ccccttgccg tcccaagcaa tggatgattt gatgctgtcc ccggacgata ttgaacaatg
      301 gttcactgaa gacccaggtc cagatgaagc tcccagaatg ccagaggctg ctccccccgt
      361 ggcccctgca ccagcagctc ctacaccggc ggcccctgca ccagccccct cctggcccct
      421 gtcatcttct gtcccttccc agaaaaccta ccagggcagc tacggtttcc gtctgggctt
      481 cttgcattct gggacagcca agtctgtgac ttgcacgtac tcccctgccc tcaacaagat
      541 gttttgccaa ctggccaaga cctgccctgt gcagctgtgg gttgattcca cacccccgcc
      601 cggcacccgc gtccgcgcca tggccatcta caagcagtca cagcacatga cggaggttgt
      661 gaggcgctgc ccccaccatg agcgctgctc agatagcgat ggtctggccc ctcctcagca
      721 tcttatccga gtggaaggaa atttgcgtgt ggagtatttg gatgacagaa acacttttcg
      781 acatagtgtg gtggtgccct atgagccgcc tgaggttggc tctgactgta ccaccatcca
      841 ctacaactac atgtgtaaca gttcctgcat gggcggcatg aaccggaggc ccatcctcac
      901 catcatcaca ctggaagact ccagtggtaa tctactggga cggaacagct ttgaggtgcg
      961 tgtttgtgcc tgtcctggga gagaccggcg cacagaggaa gagaatctcc gcaagaaagg
     1021 ggagcctcac cacgagctgc ccccagggag cactaagcga gcactgccca acaacaccag
     1081 ctcctctccc cagccaaaga agaaaccact ggatggagaa tatttcaccc ttcagatgct
     1141 acttgactta cgatggtgtt acttcctgat aaactcgtcg taagttgaaa atattatccg
     1201 tgggcgtgag cgcttcgaga tgttccgaga gctgaatgag gccttggaac tcaaggatgc
     1261 ccaggctggg aaggagccag gggggagcag ggctcactcc agccacctga agtccaaaaa
     1321 gggtcagtct acctcccgcc ataaaaaact catgttcaag acagaagggc ctgactcaga
     1381 ctgacattct ccacttcttg ttccccactg acagcctccc acccccatct ctccctcccc
     1441 tgccattttg ggttttgggt ctttgaaccc ttgcttgcaa taggtgtgcg tcagaagcac
     1501 ccaggacttc catttgcttt gtcccggggc tccactgaac aagttggcct gcactggtgt
     1561 tttgttgtgg ggaggaggat ggggagtagg acataccagc ttagatttta aggtttttac
     1621 tgtgagggat gtttgggaga tgtaagaaat gttcttgcag ttaagggtta gtttacaatc
     1681 agccacattc taggtagggg cccacttcac cgtactaacc agggaagctg tccctcactg
     1741 ttgaattttc tctaacttca aggcccatat ctgtgaaatg ctggcatttg cacctacctc
     1801 acagagtgca ttgtgagggt taatgaaata atgtacatct ggccttgaaa ccacctttta
     1861 ttacatgggg tctagaactt gacccccttg agggtgcttg ttccctctcc ctgttggtcg
     1921 gtgggttggt agtttctaca gttgggcagc tggttaggta gagggagttg tcaagtctct
     1981 gctggcccag ccaaaccctg tctgacaacc tcttggtgaa ccttagtacc taaaaggaaa
     2041 tctcacccca tcccacaccc tggaggattt catctcttgt atatgatgat ctggatccac
     2101 caagacttgt tttatgctca gggtcaattt cttttttctt tttttttttt ttttttcttt
     2161 ttctttgaga ctgggtctcg ctttgttgcc caggctggag tggagtggcg tgatcttggc
     2221 ttactgcagc ctttgcctcc ccggctcgag cagtcctgcc tcagcctccg gagtagctgg
     2281 gaccacaggt tcatgccacc atggccagcc aacttttgca tgttttgtag agatggggtc
     2341 tcacagtgtt gcccaggctg gtctcaaact cctgggctca ggcgatccac ctgtctcagc
     2401 ctcccagagt gctgggatta caattgtgag ccaccacgtc cagctggaag ggtcaacatc
     2461 ttttacattc tgcaagcaca tctgcatttt caccccaccc ttcccctcct tctccctttt
     2521 tatatcccat ttttatatcg atctcttatt ttacaataaa actttgctgc ca
//
LOCUS       NM_001126114            2645 bp    mRNA    linear   PRI 12-JUN-2025
DEFINITION  Homo sapiens tumor protein p53 (TP53), transcript variant 3, mRNA.
ACCESSION   NM_001126114
VERSION     NM_001126114.3
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (bases 1 to 2645)
  AUTHORS   Mirgayazova,R., Khadiullina,R., Chasov,V., Mingaleeva,R.,
            Miftakhova,R., Rizvanov,A. and Bulatov,E.
  TITLE     Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option?
  JOURNAL   Genes (Basel) 11 (6), 704 (2020)
   PUBMED   32630614
  REMARK    GeneRIF: Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an
            Option? Review article Publication Status: Online-Only
REFERENCE   2  (bases 1 to 2645)
  AUTHORS   Flynt,E., Bisht,K., Sridharan,V., Ortiz,M., Towfic,F. and
            Thakurta,A.
  TITLE     Prognosis, Biology, and Targeting of TP53 Dysregulation in Multiple
            Myeloma
  JOURNAL   Cells 9 (2), 287 (2020)
   PUBMED   31991614
  REMARK    Review article Publication Status: Online-Only
REFERENCE   3  (bases 1 to 2645)
  AUTHORS   Barnoud,T., Parris,J.L.D. and Murphy,M.E.
  TITLE     Common genetic variants in the TP53 pathway and their impact on
            cancer
  JOURNAL   J Mol Cell Biol 11 (7), 578-585 (2019)
   PUBMED   31152665
  REMARK    GeneRIF: Common genetic variants in the TP53 pathway and their
            impact on cancer. Review article
REFERENCE   4  (bases 1 to 2645)
  AUTHORS   Hu,W., Chen,S., Thorne,R.F. and Wu,M.
  TITLE     TP53, TP53 Target Genes (DRAM, TIGAR), and Autophagy
  JOURNAL   Adv Exp Med Biol 1206, 127-149 (2019)
   PUBMED   31776983
  REMARK    Review article
REFERENCE   5  (bases 1 to 2645)
  AUTHORS   Baugh,E.H., Ke,H., Levine,A.J., Bonneau,R.A. and Chan,C.S.
  TITLE     Why are there hotspot mutations in the TP53 gene in human cancers?
  JOURNAL   Cell Death Differ 25 (1), 154-160 (2018)
   PUBMED   29099487
  REMARK    GeneRIF: TP53 missense mutant alleles that occur in human cancers
            are discussed in the context of high resolution models of these p53
            mutant protein structures to determine the structural features of
            mutations (review). Review article
REFERENCE   6  (bases 1 to 2645)
  AUTHORS   Aubrey,B.J., Strasser,A. and Kelly,G.L.
  TITLE     Tumor-Suppressor Functions of the TP53 Pathway
  JOURNAL   Cold Spring Harb Perspect Med 6 (5), a026062 (2016)
   PUBMED   27141080
  REMARK    Review article Publication Status: Online-Only
REFERENCE   7  (bases 1 to 2645)
  AUTHORS   Soussi,T. and Wiman,K.G.
  TITLE     TP53: an oncogene in disguise
  JOURNAL   Cell Death Differ 22 (8), 1239-1249 (2015)
   PUBMED   26024390
  REMARK    Review article
REFERENCE   8  (bases 1 to 2645)
  AUTHORS   Soussi,T.
  TITLE     The TP53 gene network in a postgenomic era
  JOURNAL   Hum Mutat 35 (6), 641-642 (2014)
   PUBMED   24753184
  REMARK    GeneRIF: Recommendations and guidelines for reporting and annotating
            TP53 variants are also provided, to help researchers generate
            standardized data that are easy to understand, analyze, and exchange
            across various cancer variant databases Review article
REFERENCE   9  (bases 1 to 2645)
  AUTHORS   Anczukow,O., Ware,M.D., Buisson,M., Zetoune,A.B., Stoppa-Lyonnet,D.,
            Sinilnikova,O.M. and Mazoyer,S.
  TITLE     Does the nonsense-mediated mRNA decay mechanism prevent the
            synthesis of truncated BRCA1, CHK2, and p53 proteins?
  JOURNAL   Hum Mutat 29 (1), 65-73 (2008)
   PUBMED   17694537
  REMARK    GeneRIF: the p53 protein encoded by the 770delT allele is as
            abundant as the wild-type protein, as removal of the C-terminal p53
            domain leads to a stabilized mutant protein, whose abundance is
            markedly increased when NMD is inhibited.
REFERENCE   10  (bases 1 to 2645)
  AUTHORS   Bourdon,J.C.
  TITLE     p53 Family isoforms
  JOURNAL   Curr Pharm Biotechnol 8 (6), 332-336 (2007)
   PUBMED   18289041
  REMARK    Review article
REFERENCE   11  (bases 1 to 2645)
  AUTHORS   Candeias,M.M., Powell,D.J., Roubalova,E., Apcher,S., Bourougaa,K.,
            Vojtesek,B., Bruzzoni-Giovanelli,H. and Fahraeus,R.
  TITLE     Expression of p53 and p53/47 are controlled by alternative
            mechanisms of messenger RNA translation initiation
  JOURNAL   Oncogene 25 (52), 6936-6947 (2006)
   PUBMED   16983332
  REMARK    GeneRIF: harbouring alternative translation initiation sites, the
            p53 mRNA gives rise to different levels of the p53 isoforms which
            help to orchestrate the cell biological outcome of p53 activation
REFERENCE   12  (bases 1 to 2645)
  AUTHORS   Murray-Zmijewski,F., Lane,D.P. and Bourdon,J.C.
  TITLE     p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell
            differentiation and response to stress
  JOURNAL   Cell Death Differ 13 (6), 962-972 (2006)
   PUBMED   16601753
  REMARK    Review article
REFERENCE   13  (bases 1 to 2645)
  AUTHORS   Bourdon,J.C., Fernandes,K., Murray-Zmijewski,F., Liu,G., Diot,A.,
            Xirodimas,D.P., Saville,M.K. and Lane,D.P.
  TITLE     p53 isoforms can regulate p53 transcriptional activity
  JOURNAL   Genes Dev 19 (18), 2122-2137 (2005)
   PUBMED   16131611
  REMARK    GeneRIF: p53 isoforms can regulate p53 transcriptional activity.
REFERENCE   14  (bases 1 to 2645)
  AUTHORS   Ghosh,A., Stewart,D. and Matlashewski,G.
  TITLE     Regulation of human p53 activity and cell localization by
            alternative splicing
  JOURNAL   Mol Cell Biol 24 (18), 7987-7997 (2004)
   PUBMED   15340061
  REMARK    GeneRIF: mechanism of p53 regulation originating through alternative
            splicing of the human p53 gene resulting in the expression of a
            novel p53 mRNA
REFERENCE   15  (bases 1 to 2645)
  AUTHORS   Flaman,J.M., Waridel,F., Estreicher,A., Vannier,A., Limacher,J.M.,
            Gilbert,D., Iggo,R. and Frebourg,T.
  TITLE     The human tumour suppressor gene p53 is alternatively spliced in
            normal cells
  JOURNAL   Oncogene 12 (4), 813-818 (1996)
   PUBMED   8632903
REFERENCE   16  (bases 1 to 2645)
  AUTHORS   Schneider,K., Zelley,K., Nichols,K.E., Schwartz Levine,A. and
            Garber,J.
  TITLE     Li-Fraumeni Syndrome
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE and Amemiya
            A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301488
REFERENCE   17  (bases 1 to 2645)
  AUTHORS   Turner,J.T., Brzezinski,J. and Dome,J.S.
  TITLE     Wilms Tumor Predisposition
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE and Amemiya
            A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301471
REFERENCE   18  (bases 1 to 2645)
  AUTHORS   Lamb,P. and Crawford,L.
  TITLE     Characterization of the human p53 gene
  JOURNAL   Mol Cell Biol 6 (5), 1379-1385 (1986)
   PUBMED   2946935
REFERENCE   19  (bases 1 to 2645)
  AUTHORS   Isobe,M., Emanuel,B.S., Givol,D., Oren,M. and Croce,C.M.
  TITLE     Localization of gene for human p53 tumour antigen to band 17p13
  JOURNAL   Nature 320 (6057), 84-85 (1986)
   PUBMED   3456488
REFERENCE   20  (bases 1 to 2645)
  AUTHORS   Benchimol,S., Lamb,P., Crawford,L.V., Sheer,D., Shows,T.B.,
            Bruns,G.A. and Peacock,J.
  TITLE     Transformation associated p53 protein is encoded by a gene on human
            chromosome 17
  JOURNAL   Somat Cell Mol Genet 11 (5), 505-510 (1985)
   PUBMED   2994241
REFERENCE   21  (bases 1 to 2645)
  AUTHORS   Harlow,E., Williamson,N.M., Ralston,R., Helfman,D.M. and Adams,T.E.
  TITLE     Molecular cloning and in vitro expression of a cDNA clone for human
            cellular tumor antigen p53
  JOURNAL   Mol Cell Biol 5 (7), 1601-1610 (1985)
   PUBMED   3894933
REFERENCE   22  (bases 1 to 2645)
  AUTHORS   Zakut-Houri,R., Bienz-Tadmor,B., Givol,D. and Oren,M.
  TITLE     Human p53 cellular tumor antigen: cDNA sequence and expression in
            COS cells
  JOURNAL   EMBO J 4 (5), 1251-1255 (1985)
   PUBMED   4006916
REFERENCE   23  (bases 1 to 2645)
  AUTHORS   Matlashewski,G., Lamb,P., Pim,D., Peacock,J., Crawford,L. and
            Benchimol,S.
  TITLE     Isolation and characterization of a human p53 cDNA clone: expression
            of the human p53 gene
  JOURNAL   EMBO J 3 (13), 3257-3262 (1984)
   PUBMED   6396087
COMMENT     ##Evidence-Data-START##
            Transcript exon combination :: DQ186648.1, SRR14038196.3383531.1
            [ECO:0000332]
            RNAseq introns :: mixed sample support SAMEA1965299, SAMEA1966682
            [ECO:0006172]
            ##Evidence-Data-END##
            ##RefSeq-Attributes-START##
            NMD candidate               :: PMID: 16131611, 16601753, 18289041
            ##RefSeq-Attributes-END##
            REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from AC087388.9 and AC007421.13.
            On Aug 21, 2020 this sequence version replaced NM_001126114.2.
            Summary: This gene encodes a tumor suppressor protein containing
            transcriptional activation, DNA binding, and oligomerization
            domains. The encoded protein responds to diverse cellular stresses
            to regulate expression of target genes, thereby inducing cell cycle
            arrest, apoptosis, senescence, DNA repair, or changes in
            metabolism. Mutations in this gene are associated with a variety of
            human cancers, including hereditary cancers such as Li-Fraumeni
            syndrome. Alternative splicing of this gene and the use of
            alternate promoters result in multiple transcript variants and
            isoforms. Additional isoforms have also been shown to result from
            the use of alternate translation initiation codons from identical
            transcript variants (PMIDs: 12032546, 20937277). [provided by
            RefSeq, Dec 2016].
            CCDS Note: This CCDS ID represents the p53beta isoform described in
            PMIDs: 16131611, 16601753 and 18289041. This variant is supported
            by the transcript DQ186648.1. It should be noted that this
            transcript is predicted to undergo nonsense-mediated mRNA decay
            (NMD). However, the protein is represented because it was detected
            endogenously in PMID:16131611 using an antibody specific for the
            distinct C-terminus of this isoform. In addition, experiments in
            PMID:17694537 indicate that this gene may be somewhat less
            sensitive to NMD. A contributing factor is the presence of a
            ubiquitination domain in the C-terminus of the full-length protein,
            which makes the protein less stable under non-stress conditions.
            C-terminally truncated proteins that lack the ubiquitination
            domain, such as this isoform, are therefore more stable. NMD
            inhibition experiments in the same study show that the majority of
            NMD transcripts do indeed undergo NMD, but some low level of NMD
            escape, combined with the increased stability of C-terminally
            truncated isoforms, allows for the expression of such isoforms.
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            COMPLETENESS: full length.
FEATURES             Location/Qualifiers
     source          1..2645
                     /organism="Homo sapiens"
                     /mol_type="mRNA"
                     /db_xref="taxon:9606"
                     /chromosome="17"
                     /map="17p13.1"
     gene            1..2645
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="tumor protein p53"
                     /db_xref="GeneID:7157"
                     /db_xref="HGNC:HGNC:11998"
                     /db_xref="MIM:191170"
     exon            1..114
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     misc_feature    35..37
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="upstream in-frame stop codon"
     exon            115..216
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     CDS             143..1168
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="isoform b is encoded by transcript variant 3; tumor
                     protein 53; mutant tumor protein 53; cellular tumor antigen
                     p53; phosphoprotein p53; transformation-related protein 53;
                     antigen NY-CO-13; tumor supressor p53"
                     /codon_start=1
                     /product="cellular tumor antigen p53 isoform b"
                     /protein_id="NP_001119586.1"
                     /db_xref="CCDS:CCDS45606.1"
                     /db_xref="GeneID:7157"
                     /db_xref="HGNC:HGNC:11998"
                     /db_xref="MIM:191170"
                     /translation="MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLML
                     SPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPAAPAPAPSWPLSSSVPSQKTYQ
                     GSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIY
                     KQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEP
                     PEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVRVCACPGRD
                     RRTEEENLRKKGEPHHELPPGSTKRALPNNTSSSPQPKKKPLDGEYFTLQDQTSFQKEN
                     C"
     misc_feature    143..1102
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Interaction with CCAR2.
                     /evidence=ECO:0000269|PubMed:25732823"
     misc_feature    143..391
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Interaction with HRMT1L2.
                     /evidence=ECO:0000269|PubMed:15186775"
     misc_feature    143..274
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Transcription activation (acidic)"
     misc_feature    167..169
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="Phosphoserine, by HIPK4.
                     /evidence=ECO:0000269|PubMed:18022393; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); phosphorylation site"
     misc_feature    185..187
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="Phosphoserine, by CDK5, PRPK, AMPK, NUAK1 and ATM.
                     /evidence=ECO:0000269|PubMed:10570149,
                     ECO:0000269|PubMed:11554766, ECO:0000269|PubMed:15866171,
                     ECO:0000269|PubMed:17108107, ECO:0000269|PubMed:17591690,
                     ECO:0000269|PubMed:17967874, ECO:0000269|PubMed:21317932,
                     ECO:0000269|PubMed:28842590; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); phosphorylation site"
     misc_feature    191..217
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: TADI"
     misc_feature    194..196
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="Phosphothreonine, by CK1, VRK1 and VRK2.
                     /evidence=ECO:0000269|PubMed:10606744,
                     ECO:0000269|PubMed:10951572, ECO:0000269|PubMed:16704422,
                     ECO:0000269|PubMed:31527692; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); phosphorylation site"
     misc_feature    200..202
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="Phosphoserine, by CHEK2, CK1 and PLK3.
                     /evidence=ECO:0000269|PubMed:10570149,
                     ECO:0000269|PubMed:11447225, ECO:0000269|PubMed:11551930,
                     ECO:0000269|PubMed:12810724, ECO:0000269|PubMed:20041275;
                     propagated from UniProtKB/Swiss-Prot (P04637.4);
                     phosphorylation site"
     misc_feature    239..241
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="Phosphoserine, by CDK5 and CDK7.
                     /evidence=ECO:0000269|PubMed:17591690,
                     ECO:0000269|PubMed:9372954; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); phosphorylation site"
     misc_feature    251..253
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="Phosphoserine, by MAPKAPK5.
                     /evidence=ECO:0000269|PubMed:17254968; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); phosphorylation site"
     misc_feature    260..262
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="delta40p53beta; Region: alternative start codon"
     misc_feature    278..280
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="Phosphoserine, by CDK5, DYRK2, HIPK2 and PKC/PRKCG.
                     /evidence=ECO:0000269|PubMed:11740489,
                     ECO:0000269|PubMed:11780126, ECO:0000269|PubMed:16377624,
                     ECO:0000269|PubMed:17349958, ECO:0000269|PubMed:17591690;
                     propagated from UniProtKB/Swiss-Prot (P04637.4);
                     phosphorylation site"
     misc_feature    284..310
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: TADII"
     misc_feature    290..430
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Disordered. /evidence=ECO:0000269|PubMed:31953488"
     misc_feature    305..307
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="Phosphothreonine, by TAF1 and GRK5.
                     /evidence=ECO:0000269|PubMed:15053879,
                     ECO:0000269|PubMed:20124405; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); phosphorylation site"
     misc_feature    338..472
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Interaction with WWOX"
     misc_feature    440..1042
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Required for interaction with ZNF385A.
                     /evidence=ECO:0000269|PubMed:17719541"
     misc_feature    479..850
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Required for interaction with FBXO42.
                     /evidence=ECO:0000269|PubMed:19509332"
     misc_feature    488..1018
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Interaction with AXIN1. /evidence=ECO:0000250"
     misc_feature    500..502
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="Interaction with DNA.
                     /evidence=ECO:0000269|PubMed:16793544,
                     ECO:0000269|PubMed:18996393, ECO:0000269|PubMed:20364130;
                     propagated from UniProtKB/Swiss-Prot (P04637.4); other
                     site"
     misc_feature    500..502
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="N6-acetyllysine.
                     /evidence=ECO:0000269|PubMed:17189187,
                     ECO:0000269|PubMed:19854137, ECO:0000269|PubMed:23431171;
                     propagated from UniProtKB/Swiss-Prot (P04637.4);
                     acetylation site"
     misc_feature    689..691
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="Phosphoserine, by AURKB.
                     /evidence=ECO:0000269|PubMed:20959462; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); phosphorylation site"
     misc_feature    863..886
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Interaction with the 53BP2 SH3 domain"
     misc_feature    908..1024
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Interaction with E4F1.
                     /evidence=ECO:0000269|PubMed:10644996"
     misc_feature    947..949
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="Phosphoserine, by AURKB.
                     /evidence=ECO:0000269|PubMed:20959462; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); phosphorylation site"
     misc_feature    959..982
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Interaction with DNA"
     misc_feature    986..1117
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite"
     misc_feature    992..994
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="Phosphothreonine, by AURKB.
                     /evidence=ECO:0000269|PubMed:20959462; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); phosphorylation site"
     misc_feature    1055..1105
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="propagated from UniProtKB/Swiss-Prot (P04637.4);
                     Region: Bipartite nuclear localization signal"
     misc_feature    1055..1057
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="N6-acetyllysine.
                     /evidence=ECO:0000269|PubMed:12724314; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); acetylation site"
     misc_feature    1085..1087
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="Phosphoserine, by AURKA, CDK1 and CDK2.
                     /evidence=ECO:0000269|PubMed:10884347,
                     ECO:0000269|PubMed:14702041; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); phosphorylation site"
     misc_feature    1103..1105
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="N6-acetyllysine.
                     /evidence=ECO:0000250|UniProtKB:P02340; propagated from
                     UniProtKB/Swiss-Prot (P04637.4); acetylation site"
     exon            217..238
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            239..517
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            518..701
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            702..814
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            815..924
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            925..1061
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            1062..1135
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            1136..1268
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            1269..1375
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            1376..2645
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     regulatory      2628..2633
                     /regulatory_class="polyA_signal_sequence"
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="hexamer: AATAAA"
     polyA_site      2645
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="major polyA site"
ORIGIN
        1 ctcaaaagtc tagagccacc gtccagggag caggtagctg ctgggctccg gggacacttt
       61 gcgttcgggc tgggagcgtg ctttccacga cggtgacacg cttccctgga ttggcagcca
      121 gactgccttc cgggtcactg ccatggagga gccgcagtca gatcctagcg tcgagccccc
      181 tctgagtcag gaaacatttt cagacctatg gaaactactt cctgaaaaca acgttctgtc
      241 ccccttgccg tcccaagcaa tggatgattt gatgctgtcc ccggacgata ttgaacaatg
      301 gttcactgaa gacccaggtc cagatgaagc tcccagaatg ccagaggctg ctccccccgt
      361 ggcccctgca ccagcagctc ctacaccggc ggcccctgca ccagccccct cctggcccct
      421 gtcatcttct gtcccttccc agaaaaccta ccagggcagc tacggtttcc gtctgggctt
      481 cttgcattct gggacagcca agtctgtgac ttgcacgtac tcccctgccc tcaacaagat
      541 gttttgccaa ctggccaaga cctgccctgt gcagctgtgg gttgattcca cacccccgcc
      601 cggcacccgc gtccgcgcca tggccatcta caagcagtca cagcacatga cggaggttgt
      661 gaggcgctgc ccccaccatg agcgctgctc agatagcgat ggtctggccc ctcctcagca
      721 tcttatccga gtggaaggaa atttgcgtgt ggagtatttg gatgacagaa acacttttcg
      781 acatagtgtg gtggtgccct atgagccgcc tgaggttggc tctgactgta ccaccatcca
      841 ctacaactac atgtgtaaca gttcctgcat gggcggcatg aaccggaggc ccatcctcac
      901 catcatcaca ctggaagact ccagtggtaa tctactggga cggaacagct ttgaggtgcg
      961 tgtttgtgcc tgtcctggga gagaccggcg cacagaggaa gagaatctcc gcaagaaagg
     1021 ggagcctcac cacgagctgc ccccagggag cactaagcga gcactgccca acaacaccag
     1081 ctcctctccc cagccaaaga agaaaccact ggatggagaa tatttcaccc ttcaggacca
     1141 gaccagcttt caaaaagaaa attgttaaag agagcatgaa aatggttcta tgactttgcc
     1201 tgatacagat gctacttgac ttacgatggt gttacttcct gataaactcg tcgtaagttg
     1261 aaaatattat ccgtgggcgt gagcgcttcg agatgttccg agagctgaat gaggccttgg
     1321 aactcaagga tgcccaggct gggaaggagc caggggggag cagggctcac tccagccacc
     1381 tgaagtccaa aaagggtcag tctacctccc gccataaaaa actcatgttc aagacagaag
     1441 ggcctgactc agactgacat tctccacttc ttgttcccca ctgacagcct cccaccccca
     1501 tctctccctc ccctgccatt ttgggttttg ggtctttgaa cccttgcttg caataggtgt
     1561 gcgtcagaag cacccaggac ttccatttgc tttgtcccgg ggctccactg aacaagttgg
     1621 cctgcactgg tgttttgttg tggggaggag gatggggagt aggacatacc agcttagatt
     1681 ttaaggtttt tactgtgagg gatgtttggg agatgtaaga aatgttcttg cagttaaggg
     1741 ttagtttaca atcagccaca ttctaggtag gggcccactt caccgtacta accagggaag
     1801 ctgtccctca ctgttgaatt ttctctaact tcaaggccca tatctgtgaa atgctggcat
     1861 ttgcacctac ctcacagagt gcattgtgag ggttaatgaa ataatgtaca tctggccttg
     1921 aaaccacctt ttattacatg gggtctagaa cttgaccccc ttgagggtgc ttgttccctc
     1981 tccctgttgg tcggtgggtt ggtagtttct acagttgggc agctggttag gtagagggag
     2041 ttgtcaagtc tctgctggcc cagccaaacc ctgtctgaca acctcttggt gaaccttagt
     2101 acctaaaagg aaatctcacc ccatcccaca ccctggagga tttcatctct tgtatatgat
     2161 gatctggatc caccaagact tgttttatgc tcagggtcaa tttctttttt cttttttttt
     2221 tttttttttc tttttctttg agactgggtc tcgctttgtt gcccaggctg gagtggagtg
     2281 gcgtgatctt ggcttactgc agcctttgcc tccccggctc gagcagtcct gcctcagcct
     2341 ccggagtagc tgggaccaca ggttcatgcc accatggcca gccaactttt gcatgttttg
     2401 tagagatggg gtctcacagt gttgcccagg ctggtctcaa actcctgggc tcaggcgatc
     2461 cacctgtctc agcctcccag agtgctggga ttacaattgt gagccaccac gtccagctgg
     2521 aagggtcaac atcttttaca ttctgcaagc acatctgcat tttcacccca cccttcccct
     2581 ccttctccct ttttatatcc catttttata tcgatctctt attttacaat aaaactttgc
     2641 tgcca
//
LOCUS       NM_001276698            2136 bp    mRNA    linear   PRI 12-JUN-2025
DEFINITION  Homo sapiens tumor protein p53 (TP53), transcript variant 6, mRNA.
ACCESSION   NM_001276698
VERSION     NM_001276698.3
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (bases 1 to 2136)
  AUTHORS   Mirgayazova,R., Khadiullina,R., Chasov,V., Mingaleeva,R.,
            Miftakhova,R., Rizvanov,A. and Bulatov,E.
  TITLE     Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option?
  JOURNAL   Genes (Basel) 11 (6), 704 (2020)
   PUBMED   32630614
  REMARK    GeneRIF: Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an
            Option? Review article Publication Status: Online-Only
REFERENCE   2  (bases 1 to 2136)
  AUTHORS   Flynt,E., Bisht,K., Sridharan,V., Ortiz,M., Towfic,F. and
            Thakurta,A.
  TITLE     Prognosis, Biology, and Targeting of TP53 Dysregulation in Multiple
            Myeloma
  JOURNAL   Cells 9 (2), 287 (2020)
   PUBMED   31991614
  REMARK    Review article Publication Status: Online-Only
REFERENCE   3  (bases 1 to 2136)
  AUTHORS   Barnoud,T., Parris,J.L.D. and Murphy,M.E.
  TITLE     Common genetic variants in the TP53 pathway and their impact on
            cancer
  JOURNAL   J Mol Cell Biol 11 (7), 578-585 (2019)
   PUBMED   31152665
  REMARK    GeneRIF: Common genetic variants in the TP53 pathway and their
            impact on cancer. Review article
REFERENCE   4  (bases 1 to 2136)
  AUTHORS   Hu,W., Chen,S., Thorne,R.F. and Wu,M.
  TITLE     TP53, TP53 Target Genes (DRAM, TIGAR), and Autophagy
  JOURNAL   Adv Exp Med Biol 1206, 127-149 (2019)
   PUBMED   31776983
  REMARK    Review article
REFERENCE   5  (bases 1 to 2136)
  AUTHORS   Baugh,E.H., Ke,H., Levine,A.J., Bonneau,R.A. and Chan,C.S.
  TITLE     Why are there hotspot mutations in the TP53 gene in human cancers?
  JOURNAL   Cell Death Differ 25 (1), 154-160 (2018)
   PUBMED   29099487
  REMARK    GeneRIF: TP53 missense mutant alleles that occur in human cancers
            are discussed in the context of high resolution models of these p53
            mutant protein structures to determine the structural features of
            mutations (review). Review article
REFERENCE   6  (bases 1 to 2136)
  AUTHORS   Aubrey,B.J., Strasser,A. and Kelly,G.L.
  TITLE     Tumor-Suppressor Functions of the TP53 Pathway
  JOURNAL   Cold Spring Harb Perspect Med 6 (5), a026062 (2016)
   PUBMED   27141080
  REMARK    Review article Publication Status: Online-Only
REFERENCE   7  (bases 1 to 2136)
  AUTHORS   Soussi,T. and Wiman,K.G.
  TITLE     TP53: an oncogene in disguise
  JOURNAL   Cell Death Differ 22 (8), 1239-1249 (2015)
   PUBMED   26024390
  REMARK    Review article
REFERENCE   8  (bases 1 to 2136)
  AUTHORS   Soussi,T.
  TITLE     The TP53 gene network in a postgenomic era
  JOURNAL   Hum Mutat 35 (6), 641-642 (2014)
   PUBMED   24753184
  REMARK    GeneRIF: Recommendations and guidelines for reporting and annotating
            TP53 variants are also provided, to help researchers generate
            standardized data that are easy to understand, analyze, and exchange
            across various cancer variant databases Review article
REFERENCE   9  (bases 1 to 2136)
  AUTHORS   Anczukow,O., Ware,M.D., Buisson,M., Zetoune,A.B., Stoppa-Lyonnet,D.,
            Sinilnikova,O.M. and Mazoyer,S.
  TITLE     Does the nonsense-mediated mRNA decay mechanism prevent the
            synthesis of truncated BRCA1, CHK2, and p53 proteins?
  JOURNAL   Hum Mutat 29 (1), 65-73 (2008)
   PUBMED   17694537
  REMARK    GeneRIF: the p53 protein encoded by the 770delT allele is as
            abundant as the wild-type protein, as removal of the C-terminal p53
            domain leads to a stabilized mutant protein, whose abundance is
            markedly increased when NMD is inhibited.
REFERENCE   10  (bases 1 to 2136)
  AUTHORS   Bourdon,J.C.
  TITLE     p53 Family isoforms
  JOURNAL   Curr Pharm Biotechnol 8 (6), 332-336 (2007)
   PUBMED   18289041
  REMARK    Review article
REFERENCE   11  (bases 1 to 2136)
  AUTHORS   Candeias,M.M., Powell,D.J., Roubalova,E., Apcher,S., Bourougaa,K.,
            Vojtesek,B., Bruzzoni-Giovanelli,H. and Fahraeus,R.
  TITLE     Expression of p53 and p53/47 are controlled by alternative
            mechanisms of messenger RNA translation initiation
  JOURNAL   Oncogene 25 (52), 6936-6947 (2006)
   PUBMED   16983332
  REMARK    GeneRIF: harbouring alternative translation initiation sites, the
            p53 mRNA gives rise to different levels of the p53 isoforms which
            help to orchestrate the cell biological outcome of p53 activation
REFERENCE   12  (bases 1 to 2136)
  AUTHORS   Murray-Zmijewski,F., Lane,D.P. and Bourdon,J.C.
  TITLE     p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell
            differentiation and response to stress
  JOURNAL   Cell Death Differ 13 (6), 962-972 (2006)
   PUBMED   16601753
  REMARK    Review article
REFERENCE   13  (bases 1 to 2136)
  AUTHORS   Bourdon,J.C., Fernandes,K., Murray-Zmijewski,F., Liu,G., Diot,A.,
            Xirodimas,D.P., Saville,M.K. and Lane,D.P.
  TITLE     p53 isoforms can regulate p53 transcriptional activity
  JOURNAL   Genes Dev 19 (18), 2122-2137 (2005)
   PUBMED   16131611
  REMARK    GeneRIF: p53 isoforms can regulate p53 transcriptional activity.
REFERENCE   14  (bases 1 to 2136)
  AUTHORS   Ghosh,A., Stewart,D. and Matlashewski,G.
  TITLE     Regulation of human p53 activity and cell localization by
            alternative splicing
  JOURNAL   Mol Cell Biol 24 (18), 7987-7997 (2004)
   PUBMED   15340061
  REMARK    GeneRIF: mechanism of p53 regulation originating through alternative
            splicing of the human p53 gene resulting in the expression of a
            novel p53 mRNA
REFERENCE   15  (bases 1 to 2136)
  AUTHORS   Flaman,J.M., Waridel,F., Estreicher,A., Vannier,A., Limacher,J.M.,
            Gilbert,D., Iggo,R. and Frebourg,T.
  TITLE     The human tumour suppressor gene p53 is alternatively spliced in
            normal cells
  JOURNAL   Oncogene 12 (4), 813-818 (1996)
   PUBMED   8632903
REFERENCE   16  (bases 1 to 2136)
  AUTHORS   Schneider,K., Zelley,K., Nichols,K.E., Schwartz Levine,A. and
            Garber,J.
  TITLE     Li-Fraumeni Syndrome
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE and Amemiya
            A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301488
REFERENCE   17  (bases 1 to 2136)
  AUTHORS   Turner,J.T., Brzezinski,J. and Dome,J.S.
  TITLE     Wilms Tumor Predisposition
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE and Amemiya
            A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301471
REFERENCE   18  (bases 1 to 2136)
  AUTHORS   Lamb,P. and Crawford,L.
  TITLE     Characterization of the human p53 gene
  JOURNAL   Mol Cell Biol 6 (5), 1379-1385 (1986)
   PUBMED   2946935
REFERENCE   19  (bases 1 to 2136)
  AUTHORS   Isobe,M., Emanuel,B.S., Givol,D., Oren,M. and Croce,C.M.
  TITLE     Localization of gene for human p53 tumour antigen to band 17p13
  JOURNAL   Nature 320 (6057), 84-85 (1986)
   PUBMED   3456488
REFERENCE   20  (bases 1 to 2136)
  AUTHORS   Benchimol,S., Lamb,P., Crawford,L.V., Sheer,D., Shows,T.B.,
            Bruns,G.A. and Peacock,J.
  TITLE     Transformation associated p53 protein is encoded by a gene on human
            chromosome 17
  JOURNAL   Somat Cell Mol Genet 11 (5), 505-510 (1985)
   PUBMED   2994241
REFERENCE   21  (bases 1 to 2136)
  AUTHORS   Harlow,E., Williamson,N.M., Ralston,R., Helfman,D.M. and Adams,T.E.
  TITLE     Molecular cloning and in vitro expression of a cDNA clone for human
            cellular tumor antigen p53
  JOURNAL   Mol Cell Biol 5 (7), 1601-1610 (1985)
   PUBMED   3894933
REFERENCE   22  (bases 1 to 2136)
  AUTHORS   Zakut-Houri,R., Bienz-Tadmor,B., Givol,D. and Oren,M.
  TITLE     Human p53 cellular tumor antigen: cDNA sequence and expression in
            COS cells
  JOURNAL   EMBO J 4 (5), 1251-1255 (1985)
   PUBMED   4006916
REFERENCE   23  (bases 1 to 2136)
  AUTHORS   Matlashewski,G., Lamb,P., Pim,D., Peacock,J., Crawford,L. and
            Benchimol,S.
  TITLE     Isolation and characterization of a human p53 cDNA clone: expression
            of the human p53 gene
  JOURNAL   EMBO J 3 (13), 3257-3262 (1984)
   PUBMED   6396087
COMMENT     ##Evidence-Data-START##
            Transcript exon combination :: DQ186651.1, SRR14038191.875793.1
            [ECO:0000332]
            RNAseq introns :: mixed sample support SAMEA1965299, SAMEA1966682
            [ECO:0006172]
            ##Evidence-Data-END##
            ##RefSeq-Attributes-START##
            CDS uses downstream in-frame AUG :: experimental evidence
            (PMID:20937277)
            NMD candidate                    :: translation inferred
            ##RefSeq-Attributes-END##
            REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from DQ186651.1 and AK223026.1.
            On Aug 14, 2020 this sequence version replaced NM_001276698.2.
            Summary: This gene encodes a tumor suppressor protein containing
            transcriptional activation, DNA binding, and oligomerization
            domains. The encoded protein responds to diverse cellular stresses
            to regulate expression of target genes, thereby inducing cell cycle
            arrest, apoptosis, senescence, DNA repair, or changes in
            metabolism. Mutations in this gene are associated with a variety of
            human cancers, including hereditary cancers such as Li-Fraumeni
            syndrome. Alternative splicing of this gene and the use of
            alternate promoters result in multiple transcript variants and
            isoforms. Additional isoforms have also been shown to result from
            the use of alternate translation initiation codons from identical
            transcript variants (PMIDs: 12032546, 20937277). [provided by
            RefSeq, Dec 2016].
            Transcript Variant: This variant (6) uses an alternate promoter and
            lacks multiple 5' exons, compared to variant 1. This variant can
            initiate translation from two in-frame AUG start codons. The
            isoform represented in this variant (k, also known as
            delta160p53beta) results from translation initiation at the
            downstream start codon. It has a shorter N-terminus and a distinct
            C-terminus, compared to isoform a. This variant is supported by
            data in PMID:16131611.
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            COMPLETENESS: full length.
FEATURES             Location/Qualifiers
     source          1..2136
                     /organism="Homo sapiens"
                     /mol_type="mRNA"
                     /db_xref="taxon:9606"
                     /chromosome="17"
                     /map="17p13.1"
     gene            1..2136
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="tumor protein p53"
                     /db_xref="GeneID:7157"
                     /db_xref="HGNC:HGNC:11998"
                     /db_xref="MIM:191170"
     exon            1..192
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     misc_feature    30..32
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="alternative start codon; delta133p53beta"
     misc_feature    30..32
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="upstream_AUG_codon; putative N-terminal extension:
                     MFCQLAKTCPVQLWVDSTPPPGTRVRA"
     CDS             111..659
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="isoform k is encoded by transcript variant 6; tumor
                     protein 53; mutant tumor protein 53; cellular tumor antigen
                     p53; phosphoprotein p53; transformation-related protein 53;
                     antigen NY-CO-13; tumor supressor p53"
                     /codon_start=1
                     /product="cellular tumor antigen p53 isoform k"
                     /protein_id="NP_001263627.1"
                     /db_xref="CCDS:CCDS73965.1"
                     /db_xref="GeneID:7157"
                     /db_xref="HGNC:HGNC:11998"
                     /db_xref="MIM:191170"
                     /translation="MAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVE
                     YLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGN
                     LLGRNSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNTSSSPQPKKKP
                     LDGEYFTLQDQTSFQKENC"
     exon            193..305
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            306..415
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            416..552
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            553..626
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            627..759
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            760..866
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            867..2136
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     regulatory      2119..2124
                     /regulatory_class="polyA_signal_sequence"
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="hexamer: AATAAA"
     polyA_site      2136
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="major polyA site"
ORIGIN
        1 tcctacagta ctcccctgcc ctcaacaaga tgttttgcca actggccaag acctgccctg
       61 tgcagctgtg ggttgattcc acacccccgc ccggcacccg cgtccgcgcc atggccatct
      121 acaagcagtc acagcacatg acggaggttg tgaggcgctg cccccaccat gagcgctgct
      181 cagatagcga tggtctggcc cctcctcagc atcttatccg agtggaagga aatttgcgtg
      241 tggagtattt ggatgacaga aacacttttc gacatagtgt ggtggtgccc tatgagccgc
      301 ctgaggttgg ctctgactgt accaccatcc actacaacta catgtgtaac agttcctgca
      361 tgggcggcat gaaccggagg cccatcctca ccatcatcac actggaagac tccagtggta
      421 atctactggg acggaacagc tttgaggtgc gtgtttgtgc ctgtcctggg agagaccggc
      481 gcacagagga agagaatctc cgcaagaaag gggagcctca ccacgagctg cccccaggga
      541 gcactaagcg agcactgccc aacaacacca gctcctctcc ccagccaaag aagaaaccac
      601 tggatggaga atatttcacc cttcaggacc agaccagctt tcaaaaagaa aattgttaaa
      661 gagagcatga aaatggttct atgactttgc ctgatacaga tgctacttga cttacgatgg
      721 tgttacttcc tgataaactc gtcgtaagtt gaaaatatta tccgtgggcg tgagcgcttc
      781 gagatgttcc gagagctgaa tgaggccttg gaactcaagg atgcccaggc tgggaaggag
      841 ccagggggga gcagggctca ctccagccac ctgaagtcca aaaagggtca gtctacctcc
      901 cgccataaaa aactcatgtt caagacagaa gggcctgact cagactgaca ttctccactt
      961 cttgttcccc actgacagcc tcccaccccc atctctccct cccctgccat tttgggtttt
     1021 gggtctttga acccttgctt gcaataggtg tgcgtcagaa gcacccagga cttccatttg
     1081 ctttgtcccg gggctccact gaacaagttg gcctgcactg gtgttttgtt gtggggagga
     1141 ggatggggag taggacatac cagcttagat tttaaggttt ttactgtgag ggatgtttgg
     1201 gagatgtaag aaatgttctt gcagttaagg gttagtttac aatcagccac attctaggta
     1261 ggggcccact tcaccgtact aaccagggaa gctgtccctc actgttgaat tttctctaac
     1321 ttcaaggccc atatctgtga aatgctggca tttgcaccta cctcacagag tgcattgtga
     1381 gggttaatga aataatgtac atctggcctt gaaaccacct tttattacat ggggtctaga
     1441 acttgacccc cttgagggtg cttgttccct ctccctgttg gtcggtgggt tggtagtttc
     1501 tacagttggg cagctggtta ggtagaggga gttgtcaagt ctctgctggc ccagccaaac
     1561 cctgtctgac aacctcttgg tgaaccttag tacctaaaag gaaatctcac cccatcccac
     1621 accctggagg atttcatctc ttgtatatga tgatctggat ccaccaagac ttgttttatg
     1681 ctcagggtca atttcttttt tctttttttt tttttttttt ctttttcttt gagactgggt
     1741 ctcgctttgt tgcccaggct ggagtggagt ggcgtgatct tggcttactg cagcctttgc
     1801 ctccccggct cgagcagtcc tgcctcagcc tccggagtag ctgggaccac aggttcatgc
     1861 caccatggcc agccaacttt tgcatgtttt gtagagatgg ggtctcacag tgttgcccag
     1921 gctggtctca aactcctggg ctcaggcgat ccacctgtct cagcctccca gagtgctggg
     1981 attacaattg tgagccacca cgtccagctg gaagggtcaa catcttttac attctgcaag
     2041 cacatctgca ttttcacccc acccttcccc tccttctccc tttttatatc ccatttttat
     2101 atcgatctct tattttacaa taaaactttg ctgcca
//
LOCUS       NM_001276697            2003 bp    mRNA    linear   PRI 12-JUN-2025
DEFINITION  Homo sapiens tumor protein p53 (TP53), transcript variant 5, mRNA.
ACCESSION   NM_001276697
VERSION     NM_001276697.3
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (bases 1 to 2003)
  AUTHORS   Mirgayazova,R., Khadiullina,R., Chasov,V., Mingaleeva,R.,
            Miftakhova,R., Rizvanov,A. and Bulatov,E.
  TITLE     Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option?
  JOURNAL   Genes (Basel) 11 (6), 704 (2020)
   PUBMED   32630614
  REMARK    GeneRIF: Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an
            Option? Review article Publication Status: Online-Only
REFERENCE   2  (bases 1 to 2003)
  AUTHORS   Flynt,E., Bisht,K., Sridharan,V., Ortiz,M., Towfic,F. and
            Thakurta,A.
  TITLE     Prognosis, Biology, and Targeting of TP53 Dysregulation in Multiple
            Myeloma
  JOURNAL   Cells 9 (2), 287 (2020)
   PUBMED   31991614
  REMARK    Review article Publication Status: Online-Only
REFERENCE   3  (bases 1 to 2003)
  AUTHORS   Barnoud,T., Parris,J.L.D. and Murphy,M.E.
  TITLE     Common genetic variants in the TP53 pathway and their impact on
            cancer
  JOURNAL   J Mol Cell Biol 11 (7), 578-585 (2019)
   PUBMED   31152665
  REMARK    GeneRIF: Common genetic variants in the TP53 pathway and their
            impact on cancer. Review article
REFERENCE   4  (bases 1 to 2003)
  AUTHORS   Hu,W., Chen,S., Thorne,R.F. and Wu,M.
  TITLE     TP53, TP53 Target Genes (DRAM, TIGAR), and Autophagy
  JOURNAL   Adv Exp Med Biol 1206, 127-149 (2019)
   PUBMED   31776983
  REMARK    Review article
REFERENCE   5  (bases 1 to 2003)
  AUTHORS   Baugh,E.H., Ke,H., Levine,A.J., Bonneau,R.A. and Chan,C.S.
  TITLE     Why are there hotspot mutations in the TP53 gene in human cancers?
  JOURNAL   Cell Death Differ 25 (1), 154-160 (2018)
   PUBMED   29099487
  REMARK    GeneRIF: TP53 missense mutant alleles that occur in human cancers
            are discussed in the context of high resolution models of these p53
            mutant protein structures to determine the structural features of
            mutations (review). Review article
REFERENCE   6  (bases 1 to 2003)
  AUTHORS   Aubrey,B.J., Strasser,A. and Kelly,G.L.
  TITLE     Tumor-Suppressor Functions of the TP53 Pathway
  JOURNAL   Cold Spring Harb Perspect Med 6 (5), a026062 (2016)
   PUBMED   27141080
  REMARK    Review article Publication Status: Online-Only
REFERENCE   7  (bases 1 to 2003)
  AUTHORS   Soussi,T. and Wiman,K.G.
  TITLE     TP53: an oncogene in disguise
  JOURNAL   Cell Death Differ 22 (8), 1239-1249 (2015)
   PUBMED   26024390
  REMARK    Review article
REFERENCE   8  (bases 1 to 2003)
  AUTHORS   Soussi,T.
  TITLE     The TP53 gene network in a postgenomic era
  JOURNAL   Hum Mutat 35 (6), 641-642 (2014)
   PUBMED   24753184
  REMARK    GeneRIF: Recommendations and guidelines for reporting and annotating
            TP53 variants are also provided, to help researchers generate
            standardized data that are easy to understand, analyze, and exchange
            across various cancer variant databases Review article
REFERENCE   9  (bases 1 to 2003)
  AUTHORS   Anczukow,O., Ware,M.D., Buisson,M., Zetoune,A.B., Stoppa-Lyonnet,D.,
            Sinilnikova,O.M. and Mazoyer,S.
  TITLE     Does the nonsense-mediated mRNA decay mechanism prevent the
            synthesis of truncated BRCA1, CHK2, and p53 proteins?
  JOURNAL   Hum Mutat 29 (1), 65-73 (2008)
   PUBMED   17694537
  REMARK    GeneRIF: the p53 protein encoded by the 770delT allele is as
            abundant as the wild-type protein, as removal of the C-terminal p53
            domain leads to a stabilized mutant protein, whose abundance is
            markedly increased when NMD is inhibited.
REFERENCE   10  (bases 1 to 2003)
  AUTHORS   Bourdon,J.C.
  TITLE     p53 Family isoforms
  JOURNAL   Curr Pharm Biotechnol 8 (6), 332-336 (2007)
   PUBMED   18289041
  REMARK    Review article
REFERENCE   11  (bases 1 to 2003)
  AUTHORS   Candeias,M.M., Powell,D.J., Roubalova,E., Apcher,S., Bourougaa,K.,
            Vojtesek,B., Bruzzoni-Giovanelli,H. and Fahraeus,R.
  TITLE     Expression of p53 and p53/47 are controlled by alternative
            mechanisms of messenger RNA translation initiation
  JOURNAL   Oncogene 25 (52), 6936-6947 (2006)
   PUBMED   16983332
  REMARK    GeneRIF: harbouring alternative translation initiation sites, the
            p53 mRNA gives rise to different levels of the p53 isoforms which
            help to orchestrate the cell biological outcome of p53 activation
REFERENCE   12  (bases 1 to 2003)
  AUTHORS   Murray-Zmijewski,F., Lane,D.P. and Bourdon,J.C.
  TITLE     p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell
            differentiation and response to stress
  JOURNAL   Cell Death Differ 13 (6), 962-972 (2006)
   PUBMED   16601753
  REMARK    Review article
REFERENCE   13  (bases 1 to 2003)
  AUTHORS   Bourdon,J.C., Fernandes,K., Murray-Zmijewski,F., Liu,G., Diot,A.,
            Xirodimas,D.P., Saville,M.K. and Lane,D.P.
  TITLE     p53 isoforms can regulate p53 transcriptional activity
  JOURNAL   Genes Dev 19 (18), 2122-2137 (2005)
   PUBMED   16131611
  REMARK    GeneRIF: p53 isoforms can regulate p53 transcriptional activity.
REFERENCE   14  (bases 1 to 2003)
  AUTHORS   Ghosh,A., Stewart,D. and Matlashewski,G.
  TITLE     Regulation of human p53 activity and cell localization by
            alternative splicing
  JOURNAL   Mol Cell Biol 24 (18), 7987-7997 (2004)
   PUBMED   15340061
  REMARK    GeneRIF: mechanism of p53 regulation originating through alternative
            splicing of the human p53 gene resulting in the expression of a
            novel p53 mRNA
REFERENCE   15  (bases 1 to 2003)
  AUTHORS   Flaman,J.M., Waridel,F., Estreicher,A., Vannier,A., Limacher,J.M.,
            Gilbert,D., Iggo,R. and Frebourg,T.
  TITLE     The human tumour suppressor gene p53 is alternatively spliced in
            normal cells
  JOURNAL   Oncogene 12 (4), 813-818 (1996)
   PUBMED   8632903
REFERENCE   16  (bases 1 to 2003)
  AUTHORS   Schneider,K., Zelley,K., Nichols,K.E., Schwartz Levine,A. and
            Garber,J.
  TITLE     Li-Fraumeni Syndrome
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE and Amemiya
            A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301488
REFERENCE   17  (bases 1 to 2003)
  AUTHORS   Turner,J.T., Brzezinski,J. and Dome,J.S.
  TITLE     Wilms Tumor Predisposition
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE and Amemiya
            A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301471
REFERENCE   18  (bases 1 to 2003)
  AUTHORS   Lamb,P. and Crawford,L.
  TITLE     Characterization of the human p53 gene
  JOURNAL   Mol Cell Biol 6 (5), 1379-1385 (1986)
   PUBMED   2946935
REFERENCE   19  (bases 1 to 2003)
  AUTHORS   Isobe,M., Emanuel,B.S., Givol,D., Oren,M. and Croce,C.M.
  TITLE     Localization of gene for human p53 tumour antigen to band 17p13
  JOURNAL   Nature 320 (6057), 84-85 (1986)
   PUBMED   3456488
REFERENCE   20  (bases 1 to 2003)
  AUTHORS   Benchimol,S., Lamb,P., Crawford,L.V., Sheer,D., Shows,T.B.,
            Bruns,G.A. and Peacock,J.
  TITLE     Transformation associated p53 protein is encoded by a gene on human
            chromosome 17
  JOURNAL   Somat Cell Mol Genet 11 (5), 505-510 (1985)
   PUBMED   2994241
REFERENCE   21  (bases 1 to 2003)
  AUTHORS   Harlow,E., Williamson,N.M., Ralston,R., Helfman,D.M. and Adams,T.E.
  TITLE     Molecular cloning and in vitro expression of a cDNA clone for human
            cellular tumor antigen p53
  JOURNAL   Mol Cell Biol 5 (7), 1601-1610 (1985)
   PUBMED   3894933
REFERENCE   22  (bases 1 to 2003)
  AUTHORS   Zakut-Houri,R., Bienz-Tadmor,B., Givol,D. and Oren,M.
  TITLE     Human p53 cellular tumor antigen: cDNA sequence and expression in
            COS cells
  JOURNAL   EMBO J 4 (5), 1251-1255 (1985)
   PUBMED   4006916
REFERENCE   23  (bases 1 to 2003)
  AUTHORS   Matlashewski,G., Lamb,P., Pim,D., Peacock,J., Crawford,L. and
            Benchimol,S.
  TITLE     Isolation and characterization of a human p53 cDNA clone: expression
            of the human p53 gene
  JOURNAL   EMBO J 3 (13), 3257-3262 (1984)
   PUBMED   6396087
COMMENT     ##Evidence-Data-START##
            Transcript exon combination :: DQ186650.1, SRR14038193.783535.1
            [ECO:0000332]
            RNAseq introns :: mixed sample support SAMEA1965299, SAMEA1966682
            [ECO:0006172]
            ##Evidence-Data-END##
            ##RefSeq-Attributes-START##
            CDS uses downstream in-frame AUG :: experimental evidence
            (PMID:20937277)
            ##RefSeq-Attributes-END##
            REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from DQ186650.1 and AK223026.1.
            On Aug 14, 2020 this sequence version replaced NM_001276697.2.
            Summary: This gene encodes a tumor suppressor protein containing
            transcriptional activation, DNA binding, and oligomerization
            domains. The encoded protein responds to diverse cellular stresses
            to regulate expression of target genes, thereby inducing cell cycle
            arrest, apoptosis, senescence, DNA repair, or changes in
            metabolism. Mutations in this gene are associated with a variety of
            human cancers, including hereditary cancers such as Li-Fraumeni
            syndrome. Alternative splicing of this gene and the use of
            alternate promoters result in multiple transcript variants and
            isoforms. Additional isoforms have also been shown to result from
            the use of alternate translation initiation codons from identical
            transcript variants (PMIDs: 12032546, 20937277). [provided by
            RefSeq, Dec 2016].
            Transcript Variant: This variant (5) uses an alternate promoter and
            lacks multiple 5' exons, compared to variant 1. This variant can
            initiate translation from two in-frame AUG start codons. The
            isoform represented in this variant (j, also known as
            delta160p53alpha) results from translation initiation at the
            downstream start codon. It has a shorter N-terminus, compared to
            isoform a. This variant is supported by data in PMID:16131611.
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            COMPLETENESS: full length.
FEATURES             Location/Qualifiers
     source          1..2003
                     /organism="Homo sapiens"
                     /mol_type="mRNA"
                     /db_xref="taxon:9606"
                     /chromosome="17"
                     /map="17p13.1"
     gene            1..2003
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="tumor protein p53"
                     /db_xref="GeneID:7157"
                     /db_xref="HGNC:HGNC:11998"
                     /db_xref="MIM:191170"
     exon            1..192
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     misc_feature    30..32
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="alternative start codon; delta133p53alpha"
     misc_feature    30..32
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="upstream_AUG_codon; putative N-terminal extension:
                     MFCQLAKTCPVQLWVDSTPPPGTRVRA"
     CDS             111..815
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="isoform j is encoded by transcript variant 5; tumor
                     protein 53; mutant tumor protein 53; cellular tumor antigen
                     p53; phosphoprotein p53; transformation-related protein 53;
                     antigen NY-CO-13; tumor supressor p53"
                     /codon_start=1
                     /product="cellular tumor antigen p53 isoform j"
                     /protein_id="NP_001263626.1"
                     /db_xref="CCDS:CCDS73963.1"
                     /db_xref="GeneID:7157"
                     /db_xref="HGNC:HGNC:11998"
                     /db_xref="MIM:191170"
                     /translation="MAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVE
                     YLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGN
                     LLGRNSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNTSSSPQPKKKP
                     LDGEYFTLQIRGRERFEMFRELNEALELKDAQAGKEPGGSRAHSSHLKSKKGQSTSRHK
                     KLMFKTEGPDSD"
     exon            193..305
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            306..415
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            416..552
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            553..626
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            627..733
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            734..2003
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     regulatory      1986..1991
                     /regulatory_class="polyA_signal_sequence"
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="hexamer: AATAAA"
     polyA_site      2003
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="major polyA site"
ORIGIN
        1 tcctacagta ctcccctgcc ctcaacaaga tgttttgcca actggccaag acctgccctg
       61 tgcagctgtg ggttgattcc acacccccgc ccggcacccg cgtccgcgcc atggccatct
      121 acaagcagtc acagcacatg acggaggttg tgaggcgctg cccccaccat gagcgctgct
      181 cagatagcga tggtctggcc cctcctcagc atcttatccg agtggaagga aatttgcgtg
      241 tggagtattt ggatgacaga aacacttttc gacatagtgt ggtggtgccc tatgagccgc
      301 ctgaggttgg ctctgactgt accaccatcc actacaacta catgtgtaac agttcctgca
      361 tgggcggcat gaaccggagg cccatcctca ccatcatcac actggaagac tccagtggta
      421 atctactggg acggaacagc tttgaggtgc gtgtttgtgc ctgtcctggg agagaccggc
      481 gcacagagga agagaatctc cgcaagaaag gggagcctca ccacgagctg cccccaggga
      541 gcactaagcg agcactgccc aacaacacca gctcctctcc ccagccaaag aagaaaccac
      601 tggatggaga atatttcacc cttcagatcc gtgggcgtga gcgcttcgag atgttccgag
      661 agctgaatga ggccttggaa ctcaaggatg cccaggctgg gaaggagcca ggggggagca
      721 gggctcactc cagccacctg aagtccaaaa agggtcagtc tacctcccgc cataaaaaac
      781 tcatgttcaa gacagaaggg cctgactcag actgacattc tccacttctt gttccccact
      841 gacagcctcc cacccccatc tctccctccc ctgccatttt gggttttggg tctttgaacc
      901 cttgcttgca ataggtgtgc gtcagaagca cccaggactt ccatttgctt tgtcccgggg
      961 ctccactgaa caagttggcc tgcactggtg ttttgttgtg gggaggagga tggggagtag
     1021 gacataccag cttagatttt aaggttttta ctgtgaggga tgtttgggag atgtaagaaa
     1081 tgttcttgca gttaagggtt agtttacaat cagccacatt ctaggtaggg gcccacttca
     1141 ccgtactaac cagggaagct gtccctcact gttgaatttt ctctaacttc aaggcccata
     1201 tctgtgaaat gctggcattt gcacctacct cacagagtgc attgtgaggg ttaatgaaat
     1261 aatgtacatc tggccttgaa accacctttt attacatggg gtctagaact tgaccccctt
     1321 gagggtgctt gttccctctc cctgttggtc ggtgggttgg tagtttctac agttgggcag
     1381 ctggttaggt agagggagtt gtcaagtctc tgctggccca gccaaaccct gtctgacaac
     1441 ctcttggtga accttagtac ctaaaaggaa atctcacccc atcccacacc ctggaggatt
     1501 tcatctcttg tatatgatga tctggatcca ccaagacttg ttttatgctc agggtcaatt
     1561 tcttttttct tttttttttt tttttttctt tttctttgag actgggtctc gctttgttgc
     1621 ccaggctgga gtggagtggc gtgatcttgg cttactgcag cctttgcctc cccggctcga
     1681 gcagtcctgc ctcagcctcc ggagtagctg ggaccacagg ttcatgccac catggccagc
     1741 caacttttgc atgttttgta gagatggggt ctcacagtgt tgcccaggct ggtctcaaac
     1801 tcctgggctc aggcgatcca cctgtctcag cctcccagag tgctgggatt acaattgtga
     1861 gccaccacgt ccagctggaa gggtcaacat cttttacatt ctgcaagcac atctgcattt
     1921 tcaccccacc cttcccctcc ttctcccttt ttatatccca tttttatatc gatctcttat
     1981 tttacaataa aactttgctg cca
//
LOCUS       NM_001276696            2645 bp    mRNA    linear   PRI 12-JUN-2025
DEFINITION  Homo sapiens tumor protein p53 (TP53), transcript variant 3, mRNA.
ACCESSION   NM_001276696
VERSION     NM_001276696.3
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (bases 1 to 2645)
  AUTHORS   Mirgayazova,R., Khadiullina,R., Chasov,V., Mingaleeva,R.,
            Miftakhova,R., Rizvanov,A. and Bulatov,E.
  TITLE     Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option?
  JOURNAL   Genes (Basel) 11 (6), 704 (2020)
   PUBMED   32630614
  REMARK    GeneRIF: Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an
            Option? Review article Publication Status: Online-Only
REFERENCE   2  (bases 1 to 2645)
  AUTHORS   Flynt,E., Bisht,K., Sridharan,V., Ortiz,M., Towfic,F. and
            Thakurta,A.
  TITLE     Prognosis, Biology, and Targeting of TP53 Dysregulation in Multiple
            Myeloma
  JOURNAL   Cells 9 (2), 287 (2020)
   PUBMED   31991614
  REMARK    Review article Publication Status: Online-Only
REFERENCE   3  (bases 1 to 2645)
  AUTHORS   Barnoud,T., Parris,J.L.D. and Murphy,M.E.
  TITLE     Common genetic variants in the TP53 pathway and their impact on
            cancer
  JOURNAL   J Mol Cell Biol 11 (7), 578-585 (2019)
   PUBMED   31152665
  REMARK    GeneRIF: Common genetic variants in the TP53 pathway and their
            impact on cancer. Review article
REFERENCE   4  (bases 1 to 2645)
  AUTHORS   Hu,W., Chen,S., Thorne,R.F. and Wu,M.
  TITLE     TP53, TP53 Target Genes (DRAM, TIGAR), and Autophagy
  JOURNAL   Adv Exp Med Biol 1206, 127-149 (2019)
   PUBMED   31776983
  REMARK    Review article
REFERENCE   5  (bases 1 to 2645)
  AUTHORS   Baugh,E.H., Ke,H., Levine,A.J., Bonneau,R.A. and Chan,C.S.
  TITLE     Why are there hotspot mutations in the TP53 gene in human cancers?
  JOURNAL   Cell Death Differ 25 (1), 154-160 (2018)
   PUBMED   29099487
  REMARK    GeneRIF: TP53 missense mutant alleles that occur in human cancers
            are discussed in the context of high resolution models of these p53
            mutant protein structures to determine the structural features of
            mutations (review). Review article
REFERENCE   6  (bases 1 to 2645)
  AUTHORS   Aubrey,B.J., Strasser,A. and Kelly,G.L.
  TITLE     Tumor-Suppressor Functions of the TP53 Pathway
  JOURNAL   Cold Spring Harb Perspect Med 6 (5), a026062 (2016)
   PUBMED   27141080
  REMARK    Review article Publication Status: Online-Only
REFERENCE   7  (bases 1 to 2645)
  AUTHORS   Soussi,T. and Wiman,K.G.
  TITLE     TP53: an oncogene in disguise
  JOURNAL   Cell Death Differ 22 (8), 1239-1249 (2015)
   PUBMED   26024390
  REMARK    Review article
REFERENCE   8  (bases 1 to 2645)
  AUTHORS   Soussi,T.
  TITLE     The TP53 gene network in a postgenomic era
  JOURNAL   Hum Mutat 35 (6), 641-642 (2014)
   PUBMED   24753184
  REMARK    GeneRIF: Recommendations and guidelines for reporting and annotating
            TP53 variants are also provided, to help researchers generate
            standardized data that are easy to understand, analyze, and exchange
            across various cancer variant databases Review article
REFERENCE   9  (bases 1 to 2645)
  AUTHORS   Anczukow,O., Ware,M.D., Buisson,M., Zetoune,A.B., Stoppa-Lyonnet,D.,
            Sinilnikova,O.M. and Mazoyer,S.
  TITLE     Does the nonsense-mediated mRNA decay mechanism prevent the
            synthesis of truncated BRCA1, CHK2, and p53 proteins?
  JOURNAL   Hum Mutat 29 (1), 65-73 (2008)
   PUBMED   17694537
  REMARK    GeneRIF: the p53 protein encoded by the 770delT allele is as
            abundant as the wild-type protein, as removal of the C-terminal p53
            domain leads to a stabilized mutant protein, whose abundance is
            markedly increased when NMD is inhibited.
REFERENCE   10  (bases 1 to 2645)
  AUTHORS   Bourdon,J.C.
  TITLE     p53 Family isoforms
  JOURNAL   Curr Pharm Biotechnol 8 (6), 332-336 (2007)
   PUBMED   18289041
  REMARK    Review article
REFERENCE   11  (bases 1 to 2645)
  AUTHORS   Candeias,M.M., Powell,D.J., Roubalova,E., Apcher,S., Bourougaa,K.,
            Vojtesek,B., Bruzzoni-Giovanelli,H. and Fahraeus,R.
  TITLE     Expression of p53 and p53/47 are controlled by alternative
            mechanisms of messenger RNA translation initiation
  JOURNAL   Oncogene 25 (52), 6936-6947 (2006)
   PUBMED   16983332
  REMARK    GeneRIF: harbouring alternative translation initiation sites, the
            p53 mRNA gives rise to different levels of the p53 isoforms which
            help to orchestrate the cell biological outcome of p53 activation
REFERENCE   12  (bases 1 to 2645)
  AUTHORS   Murray-Zmijewski,F., Lane,D.P. and Bourdon,J.C.
  TITLE     p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell
            differentiation and response to stress
  JOURNAL   Cell Death Differ 13 (6), 962-972 (2006)
   PUBMED   16601753
  REMARK    Review article
REFERENCE   13  (bases 1 to 2645)
  AUTHORS   Bourdon,J.C., Fernandes,K., Murray-Zmijewski,F., Liu,G., Diot,A.,
            Xirodimas,D.P., Saville,M.K. and Lane,D.P.
  TITLE     p53 isoforms can regulate p53 transcriptional activity
  JOURNAL   Genes Dev 19 (18), 2122-2137 (2005)
   PUBMED   16131611
  REMARK    GeneRIF: p53 isoforms can regulate p53 transcriptional activity.
REFERENCE   14  (bases 1 to 2645)
  AUTHORS   Ghosh,A., Stewart,D. and Matlashewski,G.
  TITLE     Regulation of human p53 activity and cell localization by
            alternative splicing
  JOURNAL   Mol Cell Biol 24 (18), 7987-7997 (2004)
   PUBMED   15340061
  REMARK    GeneRIF: mechanism of p53 regulation originating through alternative
            splicing of the human p53 gene resulting in the expression of a
            novel p53 mRNA
REFERENCE   15  (bases 1 to 2645)
  AUTHORS   Flaman,J.M., Waridel,F., Estreicher,A., Vannier,A., Limacher,J.M.,
            Gilbert,D., Iggo,R. and Frebourg,T.
  TITLE     The human tumour suppressor gene p53 is alternatively spliced in
            normal cells
  JOURNAL   Oncogene 12 (4), 813-818 (1996)
   PUBMED   8632903
REFERENCE   16  (bases 1 to 2645)
  AUTHORS   Schneider,K., Zelley,K., Nichols,K.E., Schwartz Levine,A. and
            Garber,J.
  TITLE     Li-Fraumeni Syndrome
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE and Amemiya
            A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301488
REFERENCE   17  (bases 1 to 2645)
  AUTHORS   Turner,J.T., Brzezinski,J. and Dome,J.S.
  TITLE     Wilms Tumor Predisposition
  JOURNAL   (in) Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE and Amemiya
            A (Eds.); GENEREVIEWS(R); (1993)
   PUBMED   20301471
REFERENCE   18  (bases 1 to 2645)
  AUTHORS   Lamb,P. and Crawford,L.
  TITLE     Characterization of the human p53 gene
  JOURNAL   Mol Cell Biol 6 (5), 1379-1385 (1986)
   PUBMED   2946935
REFERENCE   19  (bases 1 to 2645)
  AUTHORS   Isobe,M., Emanuel,B.S., Givol,D., Oren,M. and Croce,C.M.
  TITLE     Localization of gene for human p53 tumour antigen to band 17p13
  JOURNAL   Nature 320 (6057), 84-85 (1986)
   PUBMED   3456488
REFERENCE   20  (bases 1 to 2645)
  AUTHORS   Benchimol,S., Lamb,P., Crawford,L.V., Sheer,D., Shows,T.B.,
            Bruns,G.A. and Peacock,J.
  TITLE     Transformation associated p53 protein is encoded by a gene on human
            chromosome 17
  JOURNAL   Somat Cell Mol Genet 11 (5), 505-510 (1985)
   PUBMED   2994241
REFERENCE   21  (bases 1 to 2645)
  AUTHORS   Harlow,E., Williamson,N.M., Ralston,R., Helfman,D.M. and Adams,T.E.
  TITLE     Molecular cloning and in vitro expression of a cDNA clone for human
            cellular tumor antigen p53
  JOURNAL   Mol Cell Biol 5 (7), 1601-1610 (1985)
   PUBMED   3894933
REFERENCE   22  (bases 1 to 2645)
  AUTHORS   Zakut-Houri,R., Bienz-Tadmor,B., Givol,D. and Oren,M.
  TITLE     Human p53 cellular tumor antigen: cDNA sequence and expression in
            COS cells
  JOURNAL   EMBO J 4 (5), 1251-1255 (1985)
   PUBMED   4006916
REFERENCE   23  (bases 1 to 2645)
  AUTHORS   Matlashewski,G., Lamb,P., Pim,D., Peacock,J., Crawford,L. and
            Benchimol,S.
  TITLE     Isolation and characterization of a human p53 cDNA clone: expression
            of the human p53 gene
  JOURNAL   EMBO J 3 (13), 3257-3262 (1984)
   PUBMED   6396087
COMMENT     ##Evidence-Data-START##
            Transcript exon combination :: DQ186648.1, SRR14038196.3383531.1
            [ECO:0000332]
            RNAseq introns :: mixed sample support SAMEA1965299, SAMEA1966682
            [ECO:0006172]
            ##Evidence-Data-END##
            ##RefSeq-Attributes-START##
            CDS uses downstream in-frame AUG :: experimental evidence
            (PMID:12032546)
            NMD candidate                    :: translation inferred
            ##RefSeq-Attributes-END##
            REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from DA453049.1, DQ186648.1,
            DQ186649.1 and AK223026.1.
            On Aug 13, 2020 this sequence version replaced NM_001276696.2.
            Summary: This gene encodes a tumor suppressor protein containing
            transcriptional activation, DNA binding, and oligomerization
            domains. The encoded protein responds to diverse cellular stresses
            to regulate expression of target genes, thereby inducing cell cycle
            arrest, apoptosis, senescence, DNA repair, or changes in
            metabolism. Mutations in this gene are associated with a variety of
            human cancers, including hereditary cancers such as Li-Fraumeni
            syndrome. Alternative splicing of this gene and the use of
            alternate promoters result in multiple transcript variants and
            isoforms. Additional isoforms have also been shown to result from
            the use of alternate translation initiation codons from identical
            transcript variants (PMIDs: 12032546, 20937277). [provided by
            RefSeq, Dec 2016].
            Transcript Variant: This variant (3) contains an additional exon in
            the 3' region, resulting in an alternate 3' coding region and 3'
            UTR, compared to variant 1. This variant can initiate translation
            from two in-frame AUG start codons. The isoform represented in this
            variant (i, also known as delta40p53beta) results from translation
            initiation at the downstream start codon. It has a shorter
            N-terminus and a distinct C-terminus, compared to isoform a.
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            COMPLETENESS: full length.
FEATURES             Location/Qualifiers
     source          1..2645
                     /organism="Homo sapiens"
                     /mol_type="mRNA"
                     /db_xref="taxon:9606"
                     /chromosome="17"
                     /map="17p13.1"
     gene            1..2645
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="tumor protein p53"
                     /db_xref="GeneID:7157"
                     /db_xref="HGNC:HGNC:11998"
                     /db_xref="MIM:191170"
     exon            1..114
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     misc_feature    35..37
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="upstream in-frame stop codon"
     exon            115..216
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     misc_feature    143..145
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="alternative start codon; p53beta"
     misc_feature    143..145
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="upstream_AUG_codon; putative N-terminal extension:
                     MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQA"
     exon            217..238
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            239..517
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     CDS             260..1168
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="isoform i is encoded by transcript variant 3; tumor
                     protein 53; mutant tumor protein 53; cellular tumor antigen
                     p53; phosphoprotein p53; transformation-related protein 53;
                     antigen NY-CO-13; tumor supressor p53"
                     /codon_start=1
                     /product="cellular tumor antigen p53 isoform i"
                     /protein_id="NP_001263625.1"
                     /db_xref="CCDS:CCDS73971.1"
                     /db_xref="GeneID:7157"
                     /db_xref="HGNC:HGNC:11998"
                     /db_xref="MIM:191170"
                     /translation="MDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPAA
                     PAPAPSWPLSSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPV
                     QLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLR
                     VEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSS
                     GNLLGRNSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNTSSSPQPKK
                     KPLDGEYFTLQDQTSFQKENC"
     exon            518..701
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            702..814
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            815..924
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            925..1061
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            1062..1135
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            1136..1268
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            1269..1375
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     exon            1376..2645
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /inference="alignment:Splign:2.1.0"
     regulatory      2628..2633
                     /regulatory_class="polyA_signal_sequence"
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="hexamer: AATAAA"
     polyA_site      2645
                     /gene="TP53"
                     /gene_synonym="BCC7; BMFS5; LFS1; P53; TRP53"
                     /note="major polyA site"
ORIGIN
        1 ctcaaaagtc tagagccacc gtccagggag caggtagctg ctgggctccg gggacacttt
       61 gcgttcgggc tgggagcgtg ctttccacga cggtgacacg cttccctgga ttggcagcca
      121 gactgccttc cgggtcactg ccatggagga gccgcagtca gatcctagcg tcgagccccc
      181 tctgagtcag gaaacatttt cagacctatg gaaactactt cctgaaaaca acgttctgtc
      241 ccccttgccg tcccaagcaa tggatgattt gatgctgtcc ccggacgata ttgaacaatg
      301 gttcactgaa gacccaggtc cagatgaagc tcccagaatg ccagaggctg ctccccccgt
      361 ggcccctgca ccagcagctc ctacaccggc ggcccctgca ccagccccct cctggcccct
      421 gtcatcttct gtcccttccc agaaaaccta ccagggcagc tacggtttcc gtctgggctt
      481 cttgcattct gggacagcca agtctgtgac ttgcacgtac tcccctgccc tcaacaagat
      541 gttttgccaa ctggccaaga cctgccctgt gcagctgtgg gttgattcca cacccccgcc
      601 cggcacccgc gtccgcgcca tggccatcta caagcagtca cagcacatga cggaggttgt
      661 gaggcgctgc ccccaccatg agcgctgctc agatagcgat ggtctggccc ctcctcagca
      721 tcttatccga gtggaaggaa atttgcgtgt ggagtatttg gatgacagaa acacttttcg
      781 acatagtgtg gtggtgccct atgagccgcc tgaggttggc tctgactgta ccaccatcca
      841 ctacaactac atgtgtaaca gttcctgcat gggcggcatg aaccggaggc ccatcctcac
      901 catcatcaca ctggaagact ccagtggtaa tctactggga cggaacagct ttgaggtgcg
      961 tgtttgtgcc tgtcctggga gagaccggcg cacagaggaa gagaatctcc gcaagaaagg
     1021 ggagcctcac cacgagctgc ccccagggag cactaagcga gcactgccca acaacaccag
     1081 ctcctctccc cagccaaaga agaaaccact ggatggagaa tatttcaccc ttcaggacca
     1141 gaccagcttt caaaaagaaa attgttaaag agagcatgaa aatggttcta tgactttgcc
     1201 tgatacagat gctacttgac ttacgatggt gttacttcct gataaactcg tcgtaagttg
     1261 aaaatattat ccgtgggcgt gagcgcttcg agatgttccg agagctgaat gaggccttgg
     1321 aactcaagga tgcccaggct gggaaggagc caggggggag cagggctcac tccagccacc
     1381 tgaagtccaa aaagggtcag tctacctccc gccataaaaa actcatgttc aagacagaag
     1441 ggcctgactc agactgacat tctccacttc ttgttcccca ctgacagcct cccaccccca
     1501 tctctccctc ccctgccatt ttgggttttg ggtctttgaa cccttgcttg caataggtgt
     1561 gcgtcagaag cacccaggac ttccatttgc tttgtcccgg ggctccactg aacaagttgg
     1621 cctgcactgg tgttttgttg tggggaggag gatggggagt aggacatacc agcttagatt
     1681 ttaaggtttt tactgtgagg gatgtttggg agatgtaaga aatgttcttg cagttaaggg
     1741 ttagtttaca atcagccaca ttctaggtag gggcccactt caccgtacta accagggaag
     1801 ctgtccctca ctgttgaatt ttctctaact tcaaggccca tatctgtgaa atgctggcat
     1861 ttgcacctac ctcacagagt gcattgtgag ggttaatgaa ataatgtaca tctggccttg
     1921 aaaccacctt ttattacatg gggtctagaa cttgaccccc ttgagggtgc ttgttccctc
     1981 tccctgttgg tcggtgggtt ggtagtttct acagttgggc agctggttag gtagagggag
     2041 ttgtcaagtc tctgctggcc cagccaaacc ctgtctgaca acctcttggt gaaccttagt
     2101 acctaaaagg aaatctcacc ccatcccaca ccctggagga tttcatctct tgtatatgat
     2161 gatctggatc caccaagact tgttttatgc tcagggtcaa tttctttttt cttttttttt
     2221 tttttttttc tttttctttg agactgggtc tcgctttgtt gcccaggctg gagtggagtg
     2281 gcgtgatctt ggcttactgc agcctttgcc tccccggctc gagcagtcct gcctcagcct
     2341 ccggagtagc tgggaccaca ggttcatgcc accatggcca gccaactttt gcatgttttg
     2401 tagagatggg gtctcacagt gttgcccagg ctggtctcaa actcctgggc tcaggcgatc
     2461 cacctgtctc agcctcccag agtgctggga ttacaattgt gagccaccac gtccagctgg
     2521 aagggtcaac atcttttaca ttctgcaagc acatctgcat tttcacccca cccttcccct
     2581 ccttctccct ttttatatcc catttttata tcgatctctt attttacaat aaaactttgc
     2641 tgcca
//
